{"content":"<li class=\"n-box-item date-title\" data-end=\"1554436799\" data-start=\"1554350400\" data-txt=\"Monday, December 23, 2019\">Thursday, April  4, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3448625\" data-ts=\"1554416279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVI\" target=\"_blank\">NAVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448625-canyon-capital-proceeds-proxy-fight-navient\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canyon Capital proceeds with proxy fight at Navient</a></h4><ul>   <li>Canyon Capital is amping up pressure on Navient (NASDAQ:<a href='https://seekingalpha.com/symbol/NAVI' title='Navient Corporation'>NAVI</a>), formally launching a rare fight for the boardroom.</li>    <li>It's <a href=\"https://www.sec.gov/Archives/edgar/data/1074034/000110465919019971/a19-7844_1pren14a.htm\" target=\"_blank\">filed a proxy statement</a> to seek four seats on the board. Canyon had <a href=\"https://seekingalpha.com/news/3436005-canyon-proposes-nominees-navient-board\" target=\"_blank\">named four nominees</a> in February.</li>    <li>Shares are <font color=\"red\">down 1.8%</font> after hours.</li>    <li>Canyon's formal filing comes after <a href=\"https://www.bloomberg.com/news/articles/2019-04-04/canyon-capital-is-said-to-start-boardroom-fight-at-navient-corp\" target=\"_blank\">talks to refresh the board</a> failed to make progress, Bloomberg reports.</li>    <li>It points out that total shareholder return has been -14% since Navient spun off from SLM in 2014.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448625\" data-linked=\"Canyon Capital proceeds with proxy fight at Navient\" data-tweet=\"$NAVI - Canyon Capital proceeds with proxy fight at Navient https://seekingalpha.com/news/3448625-canyon-capital-proceeds-proxy-fight-navient?source=tweet\" data-url=\"https://seekingalpha.com/news/3448625-canyon-capital-proceeds-proxy-fight-navient\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448620\" data-ts=\"1554414342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448620-mack-tnxp-tgi-and-dlth-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MACK, TNXP, TGI and DLTH among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/TGI' title='Triumph Group, Inc.'>TGI</a> <font color=\"green\">+6%</font>. <a href='https://seekingalpha.com/symbol/FC' title='Franklin Covey Co.'>FC</a> <font color=\"green\">+5%</font>. <a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a> <font color=\"green\">+2.7%</font>. <a href='https://seekingalpha.com/symbol/SEE' title='Sealed Air Corporation'>SEE</a> <font color=\"green\">+2.2%</font>. <a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color=\"green\">+2.1%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/SYRS' title='Syros Pharmaceuticals, Inc.'>SYRS</a> <font color=\"red\">-20.5%</font>. <a href='https://seekingalpha.com/symbol/DLTH' title='Duluth Holdings Inc.'>DLTH</a> <font color=\"red\">-18%</font>. <a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals, Inc.'>MACK</a> <font color=\"red\">-9.5%</font>. <a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a> <font color=\"red\">-9.4%</font>. <a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a> <font color=\"red\">-4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448620\" data-linked=\"MACK, TNXP, TGI and DLTH among notable after hour movers\" data-tweet=\"$TGI $FC $INSG - MACK, TNXP, TGI and DLTH among notable after hour movers https://seekingalpha.com/news/3448620-mack-tnxp-tgi-and-dlth-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448620-mack-tnxp-tgi-and-dlth-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448614\" data-ts=\"1554413061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448614-boot-barnplus-4_5-on-move-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boot Barn +4.5% on move into SmallCap 600</a></h4><ul>    <li>Boot Barn Holdings (NYSE:<a href='https://seekingalpha.com/symbol/BOOT' title='Boot Barn Holdings, Inc.'>BOOT</a>) is <font color=\"green\">up 4.5%</font> after hours on word that it's <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/904171_semtechccs-psbusboot46%282%29.pdf?force_download=true\" target=\"_blank\">moving into the S&amp;P SmallCap 600 index</a>.</li>    <li>It will replace PS Business Parks (NYSE:<a href='https://seekingalpha.com/symbol/PSB' title='PS Business Parks, Inc.'>PSB</a>), which is moving up to the MidCap 400 itself. There PSB will replace Rowan Cos. (NYSE:<a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a>), which is set to be acquired by Ensco.</li>    <li>Elsewhere, Century Communities (NYSE:<a href='https://seekingalpha.com/symbol/CCS' title='Comcast Corporation'>CCS</a>) is heading into the SmallCap 600 to replace Semtech (NASDAQ:<a href='https://seekingalpha.com/symbol/SMTC' title='Semtech Corporation'>SMTC</a>), which is moving up to the MidCap 400 to replace Arris (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRS' title='ARRIS International plc'>ARRS</a>). CommScope's <a href=\"https://seekingalpha.com/news/3448421-commscope-closes-arris-acquisition\" target=\"_blank\">deal to acquire Arris closed today</a>.</li>    <li>The index moves are effective prior to the open of trading next Thursday, April 11.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448614\" data-linked=\"Boot Barn +4.5% on move into SmallCap 600\" data-tweet=\"$BOOT $PSB $RDC - Boot Barn +4.5% on move into SmallCap 600 https://seekingalpha.com/news/3448614-boot-barnplus-4_5-on-move-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/3448614-boot-barnplus-4_5-on-move-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448609\" data-ts=\"1554411937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FE\" target=\"_blank\">FE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448609-firstenergyminus-4-after-judge-rejects-reorganization-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FirstEnergy -4% after judge rejects reorganization plan</a></h4><ul><li>FirstEnergy (NYSE:<a href='https://seekingalpha.com/symbol/FE' title='FirstEnergy Corp.'>FE</a>) shares plunged just before the close after a bankruptcy judge <a href=\"https://www.wsj.com/articles/firstenergys-bankruptcy-deal-with-power-units-collapses-11554409862\" target=\"_blank\">rejected a $4B restructuring plan</a> that would have lifted its FirstEnergy Solutions subsidiary out of Chapter 11.</li><li>The judge called the exit plan \"patently unconfirmable,\" siding with federal and state regulators who accused FE of abusing bankruptcy law to try to extricate itself from its money-losing power facilities.</li><li>FirstEnergy Solutions filed for bankruptcy last year as its FirstEnergy parent agreed to contribute $1B to pay back creditors and forgive $2.1B in claims against the unit, while FE would receive immunity from future legal claims over FES, including the costs of cleaning up and decommissioning several coal and nuclear plants.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448609\" data-linked=\"FirstEnergy -4% after judge rejects reorganization plan\" data-tweet=\"$FE - FirstEnergy -4% after judge rejects reorganization plan https://seekingalpha.com/news/3448609-firstenergyminus-4-after-judge-rejects-reorganization-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3448609-firstenergyminus-4-after-judge-rejects-reorganization-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448608\" data-ts=\"1554411792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448608-viacomplus-1_7-rbc-upgrades-on-smoother-deal-path\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viacom +1.7% as RBC upgrades on smoother deal path</a></h4><ul>   <li>Viacom (NASDAQ:<a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a>) is <font color=\"green\">up 1.7%</font> after hours after an upgrade to Outperform at RBC Capital Markets.</li>    <li>The firm notes the DirecTV negotiations came out less contentious than expected -- the two companies <a href=\"https://seekingalpha.com/news/3445288-viacom-plus-5-percent-renewing-contract-and-t-avoiding-directv-blackout\" target=\"_blank\">came to a carriage deal</a> after weekend negotiations at the end of their contract -- and that paves the way towards talking about a merger with <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>.</li>    <li>There's upside of more than 30% implied in such a merger, but \"deal or no deal, we believe Viacom is in a better spot and kudos to management,\" writes analyst Steven Cahall.</li>    <li>He's raised his price target to $36 from $31, implying 23% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448608\" data-linked=\"Viacom +1.7% as RBC upgrades on smoother deal path\" data-tweet=\"$VIAB $VIAC $VIA - Viacom +1.7% as RBC upgrades on smoother deal path https://seekingalpha.com/news/3448608-viacomplus-1_7-rbc-upgrades-on-smoother-deal-path?source=tweet\" data-url=\"https://seekingalpha.com/news/3448608-viacomplus-1_7-rbc-upgrades-on-smoother-deal-path\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448603\" data-ts=\"1554411494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVOL\" target=\"_blank\">EVOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448603-evolving-systemsminus-1_6-after-releasing-delayed-earnings-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evolving Systems -1.6% after releasing delayed earnings results</a></h4><ul>   <li>Evolving Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/EVOL' title='Evolving Systems, Inc.'>EVOL</a>) is <font color=\"red\">1.6% lower</font> after posting its <a href=\"https://seekingalpha.com/news/3448567-evolving-systems-reports-q4-results\" target=\"_blank\">Q4 earnings</a>, which had been <a href=\"https://seekingalpha.com/news/3447541-evolving-systems-postpones-earnings-last-minute-tax-question\" target=\"_blank\">delayed from earlier this week</a> at the last minute due to a tax accounting question.</li>    <li>Revenues for the quarter fell by nearly 25%, with a tough comp against the prior-year total that was boosted by one-time licenses and open project work.</li>    <li>Gross profit margin ticked up to 67.6% from 67.3%.</li>    <li>Operating loss was $17.6M, and net loss was $16M; excluding a goodwill impairment loss, it would have seen operating income of $0.2M vs. a year-ago $0.9M.</li>    <li>Similarly, net income excluding the impairment would have been $1.8M vs. a year-ago loss of $0.3M.</li>    <li>EBITDA came to $0.6M, down from last year's $1.6M.</li>    <li><a href=\"https://edge.media-server.com/m6/p/dqrujpyo\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17467431-evolving-systems-reports-2018-year-end-fourth-quarter-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3448603\" data-linked=\"Evolving Systems -1.6% after releasing delayed earnings results\" data-tweet=\"$EVOL - Evolving Systems -1.6% after releasing delayed earnings results https://seekingalpha.com/news/3448603-evolving-systemsminus-1_6-after-releasing-delayed-earnings-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3448603-evolving-systemsminus-1_6-after-releasing-delayed-earnings-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448598\" data-ts=\"1554410845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMRX\" target=\"_blank\">CMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448598-chimerix-to-regain-rights-to-antiviral-candidate-shares-up-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chimerix to regain rights to antiviral candidate; shares up 3% after hours</a></h4><ul><li>Chimerix (NASDAQ:<a href='https://seekingalpha.com/symbol/CMRX' title='Chimerix, Inc.'>CMRX</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/1117480/000111748019000014/chimerix8-kforterminationo.htm\" target=\"_blank\">discloses </a>that licensee Contravir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) will terminate its license agreement for antiviral candidate CMX157 effective June 1 after deciding to stop development.</li><li>The company will regain global rights to the lipid acyclic nucleoside phosphonate compound for all indications.</li><li>Shares are up <font color=\"green\">3%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448598\" data-linked=\"Chimerix to regain rights to antiviral candidate; shares up 3% after hours\" data-tweet=\"$CMRX $CTRV $CMRX - Chimerix to regain rights to antiviral candidate; shares up 3% after hours https://seekingalpha.com/news/3448598-chimerix-to-regain-rights-to-antiviral-candidate-shares-up-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3448598-chimerix-to-regain-rights-to-antiviral-candidate-shares-up-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448594\" data-ts=\"1554410431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLRN\" target=\"_blank\">XLRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448594-acceleron-bails-on-early-stage-candidate-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acceleron bails on early-stage candidate; shares down 4% after hours</a></h4><ul><li>Citing the frequency of anti-drug antibodies in Phase 1 participants, Acceleron Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a>) has decided to <a href=\"https://seekingalpha.com/pr/17467432-acceleron-discontinues-development-phase-1-molecule-aceminus-2494\" target=\"_blank\">terminate developmen</a>t of pipeline candidate ACE-2494, a systemic muscle agent that it felt had potential in neuromuscular disorders. The company says there were no specific adverse events, but the drug's profile did not justify advancement.</li><li>Shares are down <font color=\"red\">4%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448594\" data-linked=\"Acceleron bails on early-stage candidate; shares down 4% after hours\" data-tweet=\"$XLRN - Acceleron bails on early-stage candidate; shares down 4% after hours https://seekingalpha.com/news/3448594-acceleron-bails-on-early-stage-candidate-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3448594-acceleron-bails-on-early-stage-candidate-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448588\" data-ts=\"1554409916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYRS\" target=\"_blank\">SYRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448588-syros-down-8-after-hours-on-equity-offerings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syros down 8% after hours on equity offerings</a></h4><ul><li>Syros Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SYRS' title='Syros Pharmaceuticals, Inc.'>SYRS</a>) <a href=\"https://seekingalpha.com/pr/17467507-syros-announces-proposed-concurrent-public-offerings-common-stock-warrants-purchase-common\" target=\"_blank\">launches </a>two concurrent equity offerings, one comprised of stock and Class A warrants and the other Series A convertible preferred stock and Class A warrants.</li><li>Prices, volumes and terms have yet to be released.</li><li>Shares are down <font color=\"red\">8%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448588\" data-linked=\"Syros down 8% after hours on equity offerings\" data-tweet=\"$SYRS - Syros down 8% after hours on equity offerings https://seekingalpha.com/news/3448588-syros-down-8-after-hours-on-equity-offerings?source=tweet\" data-url=\"https://seekingalpha.com/news/3448588-syros-down-8-after-hours-on-equity-offerings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448587\" data-ts=\"1554409787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTRH\" target=\"_blank\">WTRH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448587-waitrminus-3_5-on-mixed-securities-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Waitr -3.5% on mixed securities offering</a></h4><ul><li>Waitr Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WTRH' title='Waitr Holdings Inc.'>WTRH</a>) drops after <a href=\"https://seekingalpha.com/filing/4435593\" target=\"_blank\">filing</a> for a $300M mixed securities shelf offering.</li><li>WTRH shares are <font color=\"red\">down 3.5%</font> after hours to $12.01.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448587\" data-linked=\"Waitr -3.5% on mixed securities offering\" data-tweet=\"$WTRH - Waitr -3.5% on mixed securities offering https://seekingalpha.com/news/3448587-waitrminus-3_5-on-mixed-securities-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3448587-waitrminus-3_5-on-mixed-securities-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448586\" data-ts=\"1554409615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MACK\" target=\"_blank\">MACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448586-merrimack-bails-on-lead-candidate-shares-down-9-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merrimack bails on lead candidate; shares down 9% after hours</a></h4><ul><li>Thinly traded nano cap Merrimack Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals, Inc.'>MACK</a>) slumps <font color=\"red\">9%</font> after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17467474-merrimack-discontinues-development-mmminus-310\" target=\"_blank\">announcement </a>that it is terminating development of lead drug <a href=\"https://www.merrimack.com/our-science/\" target=\"_blank\">MM-310</a> based on its safety profile. Specifically, the company does not believe that it will be able to evaluate a high enough dose, based on Phase 1 data, to reach an \"optimal therapeutic index.\"</li><li>A reduction in workforce is being planned.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448586\" data-linked=\"Merrimack bails on lead candidate; shares down 9% after hours\" data-tweet=\"$MACK - Merrimack bails on lead candidate; shares down 9% after hours https://seekingalpha.com/news/3448586-merrimack-bails-on-lead-candidate-shares-down-9-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3448586-merrimack-bails-on-lead-candidate-shares-down-9-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448582\" data-ts=\"1554409138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQB\" target=\"_blank\">AQB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448582-aquabounty-readies-equity-offering-shares-down-19-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AquaBounty readies equity offering; shares down 19% after hours</a></h4><ul><li>AquaBounty Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a>) launches a <a href=\"https://seekingalpha.com/pr/17467459-aquabounty-technologies-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offerin</a>g of common stock. Price, volume and terms have yet to be announced.</li><li>Shares are down <font color=\"red\">19%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448582\" data-linked=\"AquaBounty readies equity offering; shares down 19% after hours\" data-tweet=\"$AQB - AquaBounty readies equity offering; shares down 19% after hours https://seekingalpha.com/news/3448582-aquabounty-readies-equity-offering-shares-down-19-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3448582-aquabounty-readies-equity-offering-shares-down-19-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448574\" data-ts=\"1554409082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTH\" target=\"_blank\">DLTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448574-duluth-holdingsminus-14-after-profit-dud\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Duluth Holdings -14% after profit dud</a></h4><ul><li>Duluth Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/DLTH' title='Duluth Holdings Inc.'>DLTH</a>) sinks after Q4 EPS falls below even the lowest estimate turned in analysts.</li><li>The retailer's profit view for FY20 was even starker as it guided for revenue of $645M to $655M vs. $675M consensus and EPS of $0.74 to $0.80 vs. $1.01 consensus.</li><li>Gross margin during Q4 came in at 52.4% of sales vs. 54.0% consensus.</li><li>CEO outlook: \"Looking ahead to 2019, we will continue to expand and refine our omnichannel model with the addition of 15 stores and more holistic efforts to engage customers across channels. We will optimize the investments that we made this year by refining processes at our distribution center, the functionality of the order management systems and ecommerce platform, and our inventory planning system to improve productivity and results.\"</li><li>Shares of Duluth are <font color=\"red\">down 14.22%</font> in AH action.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448565-duluth-holdings-misses-0_11-misses-revenue\" target=\"_blank\">Duluth Holdings misses by $0.11, misses on revenue</a> (April 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448574\" data-linked=\"Duluth Holdings -14% after profit dud\" data-tweet=\"$DLTH - Duluth Holdings -14% after profit dud https://seekingalpha.com/news/3448574-duluth-holdingsminus-14-after-profit-dud?source=tweet\" data-url=\"https://seekingalpha.com/news/3448574-duluth-holdingsminus-14-after-profit-dud\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448573\" data-ts=\"1554409000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXGT\" target=\"_blank\">AXGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448573-axovant-to-reverse-split-shares-1-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axovant to reverse split shares 1:8</a></h4><ul><li>Axovant Gene Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Sciences Ltd.'>AXGT</a>) will <a href=\"https://seekingalpha.com/pr/17467464-axovant-announces-plan-effect-reverse-share-split\" target=\"_blank\">execute </a>a 1:8 reverse split of its common stock next month.</li><li>Shares are down <font color=\"red\">1%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448573\" data-linked=\"Axovant to reverse split shares 1:8\" data-tweet=\"$AXGT - Axovant to reverse split shares 1:8 https://seekingalpha.com/news/3448573-axovant-to-reverse-split-shares-1-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3448573-axovant-to-reverse-split-shares-1-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448555\" data-ts=\"1554407561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448555-judge-punts-on-musk-vs-sec-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Judge punts on Musk vs. SEC ruling</a></h4><ul><li>It was an anti-climatic end today in a Manhattan courtroom where Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) CEO Elon Musk was facing off again with the SEC over his tweeting, and facing contempt of court charges.</li><li>\"My call to action is for everyone to take a deep breath, put your reasonableness pants on and work this out,\" Judge Nathan told both parties in telling them to come back in two weeks with a resolution.</li><li>In the end, the judge didn't rule on the contempt charge.</li><li>Source: <a href=\"https://twitter.com/KlasfeldReports\" target=\"_blank\">Courtroom reporter Adam Klasfeld</a></li><li>Shares of Tesla are <font color=\"red\">down 8.07%</font> on the day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448555\" data-linked=\"Judge punts on Musk vs. SEC ruling\" data-tweet=\"$TSLA - Judge punts on Musk vs. SEC ruling https://seekingalpha.com/news/3448555-judge-punts-on-musk-vs-sec-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/3448555-judge-punts-on-musk-vs-sec-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>302&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448554\" data-ts=\"1554407346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGI\" target=\"_blank\">REGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448554-renewable-energy-started-overweight-piper-jaffray\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Renewable Energy started at Overweight by Piper Jaffray</a></h4><ul><li>Renewable Energy Group (<a href='https://seekingalpha.com/symbol/REGI' title='Renewable Energy Group, Inc.'>REGI</a> <font color='green'>+2.6%</font>) is initiated with an <a href=\"https://thefly.com/thestreet/realmoney/index.php/REGIid2888386/REGI-Renewable-Energy-initiated-with-an-Overweight-at-Piper-Jaffray\" target=\"_blank\">Overweight rating</a> and $35 price target at Piper Jaffray, which thinks recent downward pressure on the stock could provide an attractive entry point for investors.</li><li>Piper analyst Blake Fernandez sees a favorable fundamental backdrop for companies producing alternative fuels, including biodiesel, with consumers and investors \"pushing harder than ever\" for environmental conservation and governments becoming more active in encouraging the use of green fuels through regulation.</li><li>REGI is the largest U.S. producer of biodiesel, \"which places it in a prime position to capitalize on this backdrop,\" Fernandez writes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448554\" data-linked=\"Renewable Energy started at Overweight by Piper Jaffray\" data-tweet=\"$REGI - Renewable Energy started at Overweight by Piper Jaffray https://seekingalpha.com/news/3448554-renewable-energy-started-overweight-piper-jaffray?source=tweet\" data-url=\"https://seekingalpha.com/news/3448554-renewable-energy-started-overweight-piper-jaffray\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448551\" data-ts=\"1554406976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448551-appaloosa-undeterred-effort-to-split-chairman-ceo-roles-allergan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Appaloosa undeterred with effort to split Chairman/CEO roles at Allergan</a></h4><ul><li>In a return salvo to Allergan's (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"green\">+2.6%</font>) <a href=\"https://www.sec.gov/Archives/edgar/data/1578845/000119312519095747/d693768ddefa14a.htm\" target=\"_blank\">proxy statement</a> filed two days ago urging shareholders to vote against its proposal to split the Chairman and CEO roles currently held by Brent Saunders, activist investor Appaloosa LP has filed a <a href=\"https://mms.businesswire.com/media/20190404005714/en/714407/1/Appaloosa+Supplemental+AGN+Presentation+4-4-19.pdf?download=1\" target=\"_blank\">supplemental presentation</a> (re)emphasizing the many failures of Mr. Saunders.</li><li>Appaloosa cites his overly generous compensation package, including excessive stock options/grants, that fail to reflect the stock's underperformance over the past several years and the (in its opinion) lack of a clear growth-generating strategy that will right the ship.</li><li>The company's 2019 shareholders meeting is scheduled for May 1 in Dublin, Ireland.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448551\" data-linked=\"Appaloosa undeterred with effort to split Chairman/CEO roles at Allergan\" data-tweet=\"$AGN - Appaloosa undeterred with effort to split Chairman/CEO roles at Allergan https://seekingalpha.com/news/3448551-appaloosa-undeterred-effort-to-split-chairman-ceo-roles-allergan?source=tweet\" data-url=\"https://seekingalpha.com/news/3448551-appaloosa-undeterred-effort-to-split-chairman-ceo-roles-allergan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448547\" data-ts=\"1554406096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOG\" target=\"_blank\">XOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448547-colorado-oil-and-gas-names-up-sharply-late-amendment-pleases-industry\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colorado oil and gas names up sharply as late amendment pleases industry</a></h4><ul><li>Shares of oil and gas firms with a Colorado presence show surprising gains despite <a href=\"https://seekingalpha.com/news/3448205-colorado-senate-passes-oil-gas-overhaul-bill-headed-governor\" target=\"_blank\">yesterday's state senate passage</a> of sweeping changes to oil and gas laws that now awaits the governor's signature: <a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas, Inc.'>XOG</a> <font color=\"green\">+13.3%</font>, <a href='https://seekingalpha.com/symbol/PDCE' title='PDC Energy, Inc.'>PDCE</a> <font color=\"green\">+4%</font>, <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy, Inc.'>BCEI</a> <font color=\"green\">+3.3%</font>, <a href='https://seekingalpha.com/symbol/SRCI' title='SRC Energy Inc.'>SRCI</a> <font color=\"green\">+7.3%</font>, <a href='https://seekingalpha.com/symbol/HPR' title='HighPoint Resources Corporation'>HPR</a> <font color=\"green\">+6.6%</font>, <a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color=\"green\">+1%</font>, <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color=\"red\">-0.5%</font>.</li><li>While the energy industry remains firmly opposed, some members appear <a href=\"https://kdvr.com/2019/04/03/as-oil-and-gas-bill-heads-to-governors-desk-energy-industry-pleased-with-late-amendment/\" target=\"_blank\">pleased with some amendments</a>  added to the bill in recent days, such as one that says new local regulations must be \"necessary and reasonable\" as opposed to  the prior definition of simply \"reasonable.\"</li><li>\"We feel like that adds a degree of certainty for our industry,\" says the president of the Colorado Oil and Gas Association, hoping the amendment will  make it more difficult for local governments to declare outright bans on  drilling or fracking.</li><li>Industry advocates also  are <a href=\"https://www.spglobal.com/platts/en/market-insights/podcasts/oil/040319-forward-fuel-bitumen\" target=\"_blank\">pursuing a ballot initiative</a> that would effectively void the new legislation if  passed; supporters must acquire the signatures of 124,632  registered voters by Aug. 5 to get the initiative on the ballot.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448547\" data-linked=\"Colorado oil and gas names up sharply as late amendment pleases industry\" data-tweet=\"$XOG $PDCE $BCEI - Colorado oil and gas names up sharply as late amendment pleases industry https://seekingalpha.com/news/3448547-colorado-oil-and-gas-names-up-sharply-late-amendment-pleases-industry?source=tweet\" data-url=\"https://seekingalpha.com/news/3448547-colorado-oil-and-gas-names-up-sharply-late-amendment-pleases-industry\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448541\" data-ts=\"1554404235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448541-technology-movers-and-shakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology movers and shakers</a></h4><ul><li><strong>Gainers: </strong>Frontier Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) <font color=\"green\">+15%</font>. Amtech Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a>) <font color=\"green\">+12%</font>. iCAD (NASDAQ:<a href='https://seekingalpha.com/symbol/ICAD' title='iCAD, Inc.'>ICAD</a>) <font color=\"green\">+12%</font>. One Stop Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OSS' title='One Stop Systems, Inc.'>OSS</a>) <font color=\"green\">+8%</font>. Technical Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corporation'>TCCO</a>) <font color=\"green\">+8%</font>.</li> <li><strong>Losers: </strong>Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"red\">-13%</font>. B Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/BCOM' title='B Communications Ltd'>BCOM</a>) <font color=\"red\">-8%</font>. Micro Focus International (NYSE:<a href='https://seekingalpha.com/symbol/MFGP' title='Micro Focus International plc'>MFGP</a>) <font color=\"red\">-8%</font>. Zscaler (NASDAQ:<a href='https://seekingalpha.com/symbol/ZS' title='Zscaler, Inc.'>ZS</a>) <font color=\"red\">-8%</font>. SITO Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448541\" data-linked=\"Technology movers and shakers\" data-tweet=\"$FTR $ASYS $ICAD - Technology movers and shakers https://seekingalpha.com/news/3448541-technology-movers-and-shakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448541-technology-movers-and-shakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448539\" data-ts=\"1554403842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSM\" target=\"_blank\">FSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448539-fortuna-reports-updated-first-year-gold-dor-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortuna reports updated first year gold doré production</a></h4><ul><li>Fortuna Silver Mines (<a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines Inc.'>FSM</a> <font color='green'>+6.2%</font>) pushes higher after estimating gold doré production at its Lindero mine in Argentina during the first year of commercial production will come in at 145K-160K oz.</li><li>FSM says Lindero's mine plan has been optimized so the operation will  benefit from mining the higher grade mineralization outcropping that was  identified through the infill drilling completed in 2018.</li><li>FSM also reports combined proven and probable mineral reserves of 84.2M mt  containing 1.7M oz. of gold, representing a decrease of 5% in mt and 2% in contained gold ounces.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448539\" data-linked=\"Fortuna reports updated first year gold doré production\" data-tweet=\"$FSM - Fortuna reports updated first year gold doré production https://seekingalpha.com/news/3448539-fortuna-reports-updated-first-year-gold-dor-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3448539-fortuna-reports-updated-first-year-gold-dor-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448537\" data-ts=\"1554403133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448537-snapplus-2-on-launch-of-new-content-game-platform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap +2% on launch of new content, game platform</a></h4><ul>   <li>Snap (<a href=\"http://seekingalpha.com/symbol/SNAP\" target=\"_blank\">SNAP</a> <font color=\"green\">+2%</font>) has moved higher in afternoon action after announcing a spate of new content initiatives, including its gaming platform.</li>    <li>At its Partner Summit the company <a href=\"https://seekingalpha.com/pr/17467320-snap-inc-unveils-snap-games\" target=\"_blank\">announced Snap Games</a>, a real-time multiplayer platform with original games (Bitmoji Party) as well as third-party offerings from Game Closure, PikPok, Spry Fox, Zeptolab and Zynga (NASDAQ:<a href='https://seekingalpha.com/symbol/ZNGA' title='Zynga Inc.'>ZNGA</a>).</li>    <li>Players will be able to jump into games directly from Snapchat, and the offering will include monetization opportunities for Snap and its partners, including a launch with its recently unveiled non-skippable six-second video ads.</li>    <li>As expected, it announced a new <a href=\"https://seekingalpha.com/pr/17467312-snap-announces-new-slate-snap-originals-premium-shows-created-exclusively-snapchat-s-mobile\" target=\"_blank\">slate of original shows</a> for its Discover page, including serialized scripted dramas and comedies, character-driven docuseries, unscripted social commentary and other genres.</li>    <li>The company also is enhancing <a href=\"https://seekingalpha.com/pr/17467295-snap-inc-announces-new-augmented-reality-camera-search-experiences\" target=\"_blank\">augmented reality and camera search</a>, and \"App Stories\" that let Snapchatters create custom Stories for third-party apps directly from Snap's app.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448537\" data-linked=\"Snap +2% on launch of new content, game platform\" data-tweet=\"$ZNGA $SNAP - Snap +2% on launch of new content, game platform https://seekingalpha.com/news/3448537-snapplus-2-on-launch-of-new-content-game-platform?source=tweet\" data-url=\"https://seekingalpha.com/news/3448537-snapplus-2-on-launch-of-new-content-game-platform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448534\" data-ts=\"1554402898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMAN\" target=\"_blank\">EMAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448534-emaginminus-28-on-2m-direct-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EMagin -28% on $2M direct offering</a></h4><ul><li>EMagin (NYSEMKT:<a href='https://seekingalpha.com/symbol/EMAN' title='eMagin Corporation'>EMAN</a>) <font color=\"red\">plunges 28%</font> to $0.56 after <a href=\"https://seekingalpha.com/pr/17466767-emagin-corporation-announces-2-million-registered-direct-offering-common-stock\" target=\"_blank\">announcing</a> a $2M registered direct offering of its common stock.</li><li>The offering includes 4M shares sold at $0.50 each.</li><li>The company expects about $2M in gross proceeds before deducting agent fees and other offering expenses.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448534\" data-linked=\"EMagin -28% on $2M direct offering\" data-tweet=\"$EMAN - EMagin -28% on $2M direct offering https://seekingalpha.com/news/3448534-emaginminus-28-on-2m-direct-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3448534-emaginminus-28-on-2m-direct-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448525\" data-ts=\"1554401009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448525-americas-silver-and-amyris-among-energy-materials-gainers-smart-sand-and-nextdecade-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Americas Silver and Amyris among Energy/Materials gainers; Smart Sand and NextDecade among losers</a></h4><ul><li><b>Gainers: </b>Americas Silver (NYSEMKT:<a href='https://seekingalpha.com/symbol/USAS' title='Americas Silver Corporation'>USAS</a>) <font color=\"green\">+17%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+14%</font>. Extraction Oil &amp; Gas (NASDAQ:<a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas, Inc.'>XOG</a>) <font color=\"green\">+12%</font>. Penn Virginia (NASDAQ:<a href='https://seekingalpha.com/symbol/PVAC' title='Penn Virginia Corporation'>PVAC</a>) <font color=\"green\">+7%</font>. Hornbeck Offshore Services (NYSE:<a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Smart Sand (NASDAQ:<a href='https://seekingalpha.com/symbol/SND' title='Smart Sand, Inc.'>SND</a>) <font color=\"red\">-12%</font>. NextDecade (NASDAQ:<a href='https://seekingalpha.com/symbol/NEXT' title='NextDecade Corporation'>NEXT</a>) <font color=\"red\">-6%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448525\" data-linked=\"Americas Silver and Amyris among Energy/Materials gainers; Smart Sand and NextDecade among losers\" data-tweet=\"$USAS $AMRS $XOG - Americas Silver and Amyris among Energy/Materials gainers; Smart Sand and NextDecade among losers https://seekingalpha.com/news/3448525-americas-silver-and-amyris-among-energy-materials-gainers-smart-sand-and-nextdecade-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3448525-americas-silver-and-amyris-among-energy-materials-gainers-smart-sand-and-nextdecade-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448630\" data-ts=\"1554400502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WM\" target=\"_blank\">WM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448630-waste-management-downgraded-ubs-on-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Waste Management downgraded at UBS on valuation</a></h4><ul><li>Waste Management (<a href='https://seekingalpha.com/symbol/WM' title='Waste Management, Inc.'>WM</a> <font color='red'>-2%</font>) drifts lower after UBS <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/19/04/13486208/waste-management-shares-already-reflect-2019-growth-prospects-ubs-says-in-move-to-s\" target=\"_blank\">downgrades</a> shares to Neutral from Buy while raising its price target to $106 from $103, seeing a <a href=\"https://thefly.com/thestreet/realmoney/index.php/WM;RSGid2888376/WM;RSG-Waste-Management-downgraded-to-Neutral-from-Buy-at-UBS\" target=\"_blank\">more balanced risk/reward profile</a> following the stock's 17% YTD gain vs. peer Republic Services' (<a href='https://seekingalpha.com/symbol/RSG' title='Republic Services, Inc.'>RSG</a> <font color='red'>-0.5%</font>) 11% rise.</li><li>WM now trades at a 30 basis point free cash flow yield discount to RSG vs. a 50 bp average free cash yield discount in January and 70 bp average three-year discount, says UBS analyst Jon Windham.</li><li>Although a recycling recovery is unlikely in 2019, last year's recycling headwind should ease due to more stable pricing and rising contamination fees, Windham says.</li><li>The analyst also notes that solid waste volume and price growth historically have lagged key economic indicators such as housing starts and GDP by 1-3 years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448630\" data-linked=\"Waste Management downgraded at UBS on valuation\" data-tweet=\"$WM $RSG - Waste Management downgraded at UBS on valuation https://seekingalpha.com/news/3448630-waste-management-downgraded-ubs-on-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3448630-waste-management-downgraded-ubs-on-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448517\" data-ts=\"1554399013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMPL\" target=\"_blank\">SMPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448517-simply-good-foods-runs-to-all-time-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Simply Good Foods runs to all-time high</a></h4><ul> <li>Simply Good Foods (<a href='https://seekingalpha.com/symbol/SMPL' title='The Simply Good Foods Company'>SMPL</a> <font color='green'>+0.6%</font>) gains after topping EBITDA estimates for FQ2 ($23M vs. $20M consensus) and guiding for double-digit full-year sales and adjusted EBITDA growth.</li> <li>Shares of Simply Good Foods traded at an all-time high of $23.28 earlier in the session.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3448429-simply-good-foods-q2-earnings\" target=\"_blank\">More on Simply Good Foods Q2 earnings</a> (April 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448517\" data-linked=\"Simply Good Foods runs to all-time high\" data-tweet=\"$SMPL - Simply Good Foods runs to all-time high https://seekingalpha.com/news/3448517-simply-good-foods-runs-to-all-time-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3448517-simply-good-foods-runs-to-all-time-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448628\" data-ts=\"1554398134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RES\" target=\"_blank\">RES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448628-rpcplus-5-morgan-stanley-double-upgrades-frack-sentiment-trough\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RPC +5% as Morgan Stanley double upgrades with frack sentiment at trough</a></h4><ul><li>RPC Inc. (<a href='https://seekingalpha.com/symbol/RES' title='RPC, Inc.'>RES</a> <font color='green'>+5.6%</font>) surges after Morgan Stanley issues a <a href=\"https://thefly.com/thestreet/realmoney/index.php/RESid2888439/RES-RPC-Inc-upgraded-to-Overweight-from-Underweight-at-Morgan-Stanley\" target=\"_blank\">double upgrade</a> for the oilfield services company to Overweight from Underweight with a $15 price target raised from $11, seeing a cyclical buying opportunity with frac market sentiment at a trough.</li><li>Stanley analyst Connor Lynagh says RPC's exposure to smaller E&amp;Ps in the Permian Basin and a more dynamic pricing model should allow the company to take advantage of any upside surprises in market tightness or pricing faster and more significantly than peers.</li><li>Additionally, the stock has lagged peers by more than 15% YTD, which Lynagh attributes to concerns about its more \"spot work\" oriented model.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448628\" data-linked=\"RPC +5% as Morgan Stanley double upgrades with frack sentiment at trough\" data-tweet=\"$RES - RPC +5% as Morgan Stanley double upgrades with frack sentiment at trough https://seekingalpha.com/news/3448628-rpcplus-5-morgan-stanley-double-upgrades-frack-sentiment-trough?source=tweet\" data-url=\"https://seekingalpha.com/news/3448628-rpcplus-5-morgan-stanley-double-upgrades-frack-sentiment-trough\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448509\" data-ts=\"1554397684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448509-yangtze-river-port-and-logistics-only-financial-gainer-oxbridge-re-holdings-and-atlas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yangtze River Port and Logistics the only financial gainer; Oxbridge Re Holdings and Atlas Financial among losers</a></h4><ul><li><b>Gainers:</b> Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"green\">+48%</font>.</li><li><b>Losers:</b> Oxbridge Re Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a>) <font color=\"red\">-9%</font>. Atlas Financial Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings, Inc.'>AFH</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448509\" data-linked=\"Yangtze River Port and Logistics the only financial gainer; Oxbridge Re Holdings and Atlas Financial among losers\" data-tweet=\"$YRIV $OXBR $AFH - Yangtze River Port and Logistics the only financial gainer; Oxbridge Re Holdings and Atlas Financial among losers https://seekingalpha.com/news/3448509-yangtze-river-port-and-logistics-only-financial-gainer-oxbridge-re-holdings-and-atlas?source=tweet\" data-url=\"https://seekingalpha.com/news/3448509-yangtze-river-port-and-logistics-only-financial-gainer-oxbridge-re-holdings-and-atlas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448507\" data-ts=\"1554397262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448507-triumph-group-and-hudson-technologies-among-industrial-gainers-ocean-power-technologies-leads\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Triumph Group and Hudson Technologies among industrial gainers; Ocean Power Technologies leads the losers</a></h4><ul><li><b>Gainers: </b>Servotronics (NYSEMKT:<a href='https://seekingalpha.com/symbol/SVT' title='Servotronics, Inc.'>SVT</a>) <font color=\"green\">+11%</font>. Triumph Group (NYSE:<a href='https://seekingalpha.com/symbol/TGI' title='Triumph Group, Inc.'>TGI</a>) <font color=\"green\">+7%</font>. Hudson Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies Inc.'>HDSN</a>) <font color=\"green\">+6%</font>. Perma-Fix Environmental Services (NASDAQ:<a href='https://seekingalpha.com/symbol/PESI' title='Perma-Fix Environmental Services, Inc.'>PESI</a>) <font color=\"green\">+5%</font>. ReTo Eco-Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/RETO' title='ReTo Eco-Solutions, Inc.'>RETO</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"red\">-60%</font>. Research Frontiers (NASDAQ:<a href='https://seekingalpha.com/symbol/REFR' title='Research Frontiers Incorporated'>REFR</a>) <font color=\"red\">-7%</font>. Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448507\" data-linked=\"Triumph Group and Hudson Technologies among industrial gainers; Ocean Power Technologies leads the losers\" data-tweet=\"$SVT $TGI $HDSN - Triumph Group and Hudson Technologies among industrial gainers; Ocean Power Technologies leads the losers https://seekingalpha.com/news/3448507-triumph-group-and-hudson-technologies-among-industrial-gainers-ocean-power-technologies-leads?source=tweet\" data-url=\"https://seekingalpha.com/news/3448507-triumph-group-and-hudson-technologies-among-industrial-gainers-ocean-power-technologies-leads\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448504\" data-ts=\"1554396793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448504-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers</strong>: Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"green\">+48%</font>. Recro Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/REPH' title='Recro Pharma, Inc.'>REPH</a>) <font color=\"green\">+28%</font>. Shineco (NASDAQ:<a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a>) <font color=\"green\">+27%</font>. SG Blocks (NASDAQ:<a href='https://seekingalpha.com/symbol/SGBX' title='SG Blocks, Inc.'>SGBX</a>) <font color=\"green\">+18%</font>. Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"green\">+18%</font>. Amtech Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a>) <font color=\"green\">+15%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+13%</font>. Americas Silver (NYSEMKT:<a href='https://seekingalpha.com/symbol/USAS' title='Americas Silver Corporation'>USAS</a>) <font color=\"green\">+13%</font>. Ballantyne Strong (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTN' title='Ballantyne Strong, Inc'>BTN</a>) <font color=\"green\">+13%</font>. Extraction Oil &amp; Gas (NASDAQ:<a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas, Inc.'>XOG</a>) <font color=\"green\">+13%</font>.</li> <li><strong>Losers: </strong>Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"red\">-60%</font>.InspireMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a>) <font color=\"red\">-38%</font>. AVEO Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) <font color=\"red\">-27%</font>. Reebonz Holding Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/RBZ' title='Reebonz Holding Limited'>RBZ</a>) <font color=\"red\">-24%</font>. Pulmatrix (NASDAQ:<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a>) <font color=\"red\">-24%</font>. Office Depot (NASDAQ:<a href='https://seekingalpha.com/symbol/ODP' title='Office Depot, Inc.'>ODP</a>) <font color=\"red\">-20%</font>. ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a>) <font color=\"red\">-19%</font>. Resources Connection (NASDAQ:<a href='https://seekingalpha.com/symbol/RECN' title='Resources Connection, Inc.'>RECN</a>) <font color=\"red\">-15%</font>. Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"red\">-12%</font>. Adaptimmune Therapeutics plc (NASDAQ:<a href='https://seekingalpha.com/symbol/ADAP' title='Adaptimmune Therapeutics plc'>ADAP</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448504\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$YRIV $REPH $TYHT - Midday Gainers / Losers https://seekingalpha.com/news/3448504-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448504-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448512\" data-ts=\"1554396755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448512-boeing-says-software-fix-will-always-allow-override-of-anti-stall-system\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing says software fix will always allow override of anti-stall system</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+2.4%</font>) says a new software fix for its anti-stall system will give pilots the authority to <a href=\"https://www.reuters.com/article/us-ethiopia-airplane-boeing/boeing-says-software-fix-will-always-allow-crew-to-override-anti-stall-system-idUSKCN1RG24S?il=0\" target=\"_blank\">always override the system</a> if activated by faulty sensor data.</li><li>In a <a href=\"https://seekingalpha.com/pr/17467163-boeing-statement-ethiopian-airlines-flight-302-investigation-preliminary-report\" target=\"_blank\">company statement</a>, BA says its update \"adds additional layers of protection and will prevent erroneous data from causing MCAS activation. Flight crews will always have the ability to override MCAS and manually control the airplane.\"</li><li>The anti-stall system activated in the Ethiopian Airlines crash last month and also during last October's Lion Air crash in Indonesia, Boeing said in the statement that follows the release of <a href=\"https://seekingalpha.com/news/3448483-boeing-plus-3-percent-what-street-expects-fix-737-max-problems\" target=\"_blank\">preliminary findings from Ethiopia</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448512\" data-linked=\"Boeing says software fix will always allow override of anti-stall system\" data-tweet=\"$BA - Boeing says software fix will always allow override of anti-stall system https://seekingalpha.com/news/3448512-boeing-says-software-fix-will-always-allow-override-of-anti-stall-system?source=tweet\" data-url=\"https://seekingalpha.com/news/3448512-boeing-says-software-fix-will-always-allow-override-of-anti-stall-system\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448498\" data-ts=\"1554395414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448498-amazon-preps-generic-move-pharmacies-drop-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon preps generic move, pharmacies drop - report</a></h4><ul><li>Cleveland Research analyst Rob Eich says Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='red'>-0.5%</font>) could make a \"more meaningful move\" into U.S. pharmacies in the next six to 12 months, focusing on Prime members wanting to pay cash for generic medications.</li><li>The analyst says Amazon is looking at tele- and self-service pharmacies, utilizing its own lockers, and \"fringe markets\" like discount drug cards and correctional facilities.</li><li>Retail pharmacies and drug distributors that could move on the note: Rite Aid (<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color='red'>-1.1%</font>), Walgreens Boots (<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a> <font color='red'>-1.2%</font>), Cardinal Health (<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health, Inc.'>CAH</a> <font color='red'>-0.9%</font>), McKesson (<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color='red'>-0.9%</font>), Diplomat Pharmacy (<a href='https://seekingalpha.com/symbol/DPLO' title='Diplomat Pharmacy, Inc.'>DPLO</a> <font color='red'>-0.7%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3448498\" data-linked=\"Amazon preps generic move, pharmacies drop - report\" data-tweet=\"$AMZN $AMZN $RAD - Amazon preps generic move, pharmacies drop - report https://seekingalpha.com/news/3448498-amazon-preps-generic-move-pharmacies-drop-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3448498-amazon-preps-generic-move-pharmacies-drop-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>152&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448492\" data-ts=\"1554395239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGO\" target=\"_blank\">PRGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448492-pe-firms-eyeing-perrigo-pharma-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PE firms eyeing Perrigo pharma business</a></h4><ul><li>Private equity shops Apollo Global Management and CVC Capital Partners are apparently <a href=\"https://www.bloomberg.com/news/articles/2019-04-04/apollo-cvc-said-to-be-vying-for-perrigo-s-pharmaceuticals-unit\" target=\"_blank\">bidding</a> for Perrigo's (<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company plc'>PRGO</a> <font color=\"green\">+2.6%</font>) generic pharmaceuticals unit according to informed sources who add that the business could fetch more than $2.5B.</li><li>The news seems to have stoked an uptick in buying in other generics players.</li><li>Selected tickers: Akorn (<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color=\"green\">+0.9%</font>); ANI Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ANIP' title='ANI Pharmaceuticals, Inc.'>ANIP</a> <font color=\"green\">+1.3%</font>); Amphastar Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar Pharmaceuticals, Inc.'>AMPH</a> <font color=\"green\">+1.9%</font>); Coherus BioSciences (<a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences, Inc.'>CHRS</a> <font color=\"green\">+0.7%</font>); Collegium Pharmaceutical (<a href='https://seekingalpha.com/symbol/COLL' title='Collegium Pharmaceutical, Inc.'>COLL</a> <font color=\"green\">+1.3%</font>); Mallinckrodt (<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a> <font color=\"green\">+2.1%</font>); Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"green\">+1.7%</font>); Lannett Company (<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc.'>LCI</a> <font color=\"green\">+0.4%</font>); Mylan (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan N.V.'>MYL</a> <font color=\"green\">+1.5%</font>); Aclaris Therapeutics (<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics, Inc.'>ACRS</a> <font color=\"green\">+0.2%</font>); Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"green\">+0.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448492\" data-linked=\"PE firms eyeing Perrigo pharma business\" data-tweet=\"$PRGO $AKRX $ANIP - PE firms eyeing Perrigo pharma business https://seekingalpha.com/news/3448492-pe-firms-eyeing-perrigo-pharma-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3448492-pe-firms-eyeing-perrigo-pharma-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448495\" data-ts=\"1554394802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFGP\" target=\"_blank\">MFGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448495-micro-focusminus-7_8-on-citi-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micro Focus -7.8% on Citi Sell</a></h4><ul><li>Micro Focus (NYSE:<a href='https://seekingalpha.com/symbol/MFGP' title='Micro Focus International plc'>MFGP</a>) <font color=\"red\">drops 7.8%</font> after Citi's overseas research call downgrading the company from Neutral to Sell with a £17 price target.</li><li>Citi says Micro Focus has \"run ahead of fundamentals,\" and investors are ignoring the earnings risk and mispricing the long-term FCF potential.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448495\" data-linked=\"Micro Focus -7.8% on Citi Sell\" data-tweet=\"$MFGP - Micro Focus -7.8% on Citi Sell https://seekingalpha.com/news/3448495-micro-focusminus-7_8-on-citi-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3448495-micro-focusminus-7_8-on-citi-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448484\" data-ts=\"1554393813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SECO\" target=\"_blank\">SECO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448484-on-secoos-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Secoo&#39;s Q4 results</a></h4><ul><li>Secoo (<a href='https://seekingalpha.com/symbol/SECO' title='Secoo Holding Limited'>SECO</a> <font color=\"red\">-0.1%</font>) reported Q4 revenue growth of 27% Y/Y to RMB 1.79B, driven by the strong growth in marketing campaigns during the period.</li><li>GMV reached RMB3.08B an increase of 58.5% Y/Y.</li><li>Total number of orders 945.2k (+72% Y/Y); and Number of active customers were 406k (+79.9% Y/Y).</li><li>Q4 Gross margin <font color=\"green\">improved by 320 bps</font> to 18.7%; and operating margin<font color=\"green\"> improved by 300 bps</font> to 3.8%.</li><li>Adj. operating margin <font color=\"green\">improved by 50 bps</font> to 4.2%.</li><li>Company had cash, time deposits, and restricted cash of RMB1.2B, as of December 31, 2018.</li><li>From 4Q18 to date, Secoo continued direct collaboration efforts, adding over 100 brands, including sought-after international fashion and fashion brands such as Michael Kors, Ports, Marni, Trussardi, Rene Caovilla, Moose Knuckles, Jason Wu, MSGM, Paul &amp; Joe and Jenny Packham.</li><li><strong>1Q19 Guidance:</strong> Revenue in the range of RMB9.7B to RMB10.7B, representing an increase of ~21% to 33%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448330-secoo-misses-0_06-misses-revenue\" target=\"_blank\">Secoo misses by $0.06, misses on revenue</a> (April 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448484\" data-linked=\"More on Secoo&#39;s Q4 results\" data-tweet=\"$SECO - More on Secoo&#39;s Q4 results https://seekingalpha.com/news/3448484-on-secoos-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3448484-on-secoos-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448487\" data-ts=\"1554393776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448487-kandi-technologies-and-home-group-among-consumer-gainers-tesla-and-landec-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kandi Technologies and At Home Group among consumer gainers; Tesla and Landec among losers</a></h4><ul><li><b>Gainers: </b>Ballantyne Strong (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTN' title='Ballantyne Strong, Inc'>BTN</a>) <font color=\"green\">+12%</font>. At Home Group (NYSE:<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group Inc.'>HOME</a>) <font color=\"green\">+7%</font>. KBS Fashion Group (NASDAQ:<a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a>) <font color=\"green\">+6%</font>. Kandi Technologies Group (NASDAQ:<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Landec (NASDAQ:<a href='https://seekingalpha.com/symbol/LNDC' title='Landec Corporation'>LNDC</a>) <font color=\"red\">-10%</font>. Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <font color=\"red\">-8%</font>. Arcimoto (NASDAQ:<a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a>) <font color=\"red\">-7%</font>. Fuling Global (NASDAQ:<a href='https://seekingalpha.com/symbol/FORK' title='Fuling Global Inc.'>FORK</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448487\" data-linked=\"Kandi Technologies and At Home Group among consumer gainers; Tesla and Landec among losers\" data-tweet=\"$BTN $HOME $KBSF - Kandi Technologies and At Home Group among consumer gainers; Tesla and Landec among losers https://seekingalpha.com/news/3448487-kandi-technologies-and-home-group-among-consumer-gainers-tesla-and-landec-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448487-kandi-technologies-and-home-group-among-consumer-gainers-tesla-and-landec-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448483\" data-ts=\"1554393308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448483-boeingplus-3-what-street-expects-to-fix-737-max-problems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing +3% as it does &#39;what the Street expects&#39; to fix 737 MAX problems</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color=\"green\">+2.7%</font>) is a key driver in today's Dow outperformance following reports of a  <a href=\"https://seekingalpha.com/news/3448275-boeing-says-new-737-max-software-test-success\" target=\"_blank\">successful test of the software fix</a> for the 737 MAX plane, which included CEO Dennis Muilenburg flying in the cockpit with pilots as the test was conducted.</li><li>Despite the torrent of negative news, Teresa Rivas of <em>Barron's</em> says the worst may be over for Boeing because the company is \"<a href=\"https://www.barrons.com/articles/boeing-stock-737-max-software-patch-51554387680\" target=\"_blank\">doing what the Street expects to fix the situation, and swiftly</a>,\" as the software patch appears to be working and on schedule.</li><li>Meanwhile, Ethiopian investigators are urging Boeing to review its flight control technology and say Ethiopian Airlines pilots had <a href=\"https://www.reuters.com/article/us-ethiopia-airplane-crew-software/ethiopia-urges-boeing-to-review-737-max-controls-backs-pilots-idUSKCN1RG0R4\" target=\"_blank\">carried out proper procedures</a>, in the first public findings on the 737 MAX crash that killed 157 people.</li><li>\"The crew performed all the procedures repeatedly provided by the manufacturer but was not able to control the aircraft,\" Ethiopian Transport Minister Dagmawit Moges told a news conference.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448483\" data-linked=\"Boeing +3% as it does &#39;what the Street expects&#39; to fix 737 MAX problems\" data-tweet=\"$BA - Boeing +3% as it does &#39;what the Street expects&#39; to fix 737 MAX problems https://seekingalpha.com/news/3448483-boeingplus-3-what-street-expects-to-fix-737-max-problems?source=tweet\" data-url=\"https://seekingalpha.com/news/3448483-boeingplus-3-what-street-expects-to-fix-737-max-problems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448481\" data-ts=\"1554393207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448481-l3-harris-shareholders-approve-merger-of-equals-shares-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">L3, Harris shareholders approve merger of equals; shares rise</a></h4><ul>   <li>In a pair of special meetings, shareholders of L3 Technologies (<a href=\"http://seekingalpha.com/symbol/LLL\" target=\"_blank\">LLL</a> <font color=\"green\">+1.9%</font>) and Harris (<a href=\"http://seekingalpha.com/symbol/HRS\" target=\"_blank\">HRS</a> <font color=\"green\">+1.8%</font>) have <a href=\"https://seekingalpha.com/pr/17467085-harris-corporation-l3-technologies-stockholders-approve-merger\" target=\"_blank\">approved all proposals needed to merge the companies</a>.</li>    <li>The result in a merger of equals will be L3 Harris Technologies. The deal's set to close in mid-2019 after it receives needed regulatory approvals.</li>    <li>Final voting results will be filed with separate form 8-Ks filed with the SEC after they're certified.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448481\" data-linked=\"L3, Harris shareholders approve merger of equals; shares rise\" data-tweet=\"$LLL $LHX - L3, Harris shareholders approve merger of equals; shares rise https://seekingalpha.com/news/3448481-l3-harris-shareholders-approve-merger-of-equals-shares-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/3448481-l3-harris-shareholders-approve-merger-of-equals-shares-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448472\" data-ts=\"1554391822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448472-roku-offers-hbo-in-roku-channel-premium-subscriptions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku offers HBO in Roku Channel premium subscriptions</a></h4><ul>    <li>Roku (<a href=\"http://seekingalpha.com/symbol/ROKU\" target=\"_blank\">ROKU</a> <font color=\"red\">-7.9%</font>) today has <a href=\"https://seekingalpha.com/pr/17466765-roku-adds-hbo-premium-subscriptions-roku-channel\" target=\"_blank\">added HBO</a> (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"green\">+0.4%</font>) to its premium subscriptions offering on the Roku Channel, in time for the premiere of the final season of <i>Game of Thrones.</i></li>    <li>Channel users can try the premium service free for seven days before being charged $14.99/month.</li>    <li>Cinemax will soon be available via premium subscriptions, which now number more than 25 offered by Roku.</li>    <li>Roku shares are reeling a bit following a <a href=\"https://seekingalpha.com/news/3448329-roku-loses-bull-guggenheim-shares-2_7-percent\" target=\"_blank\">ratings cut to Neutral</a> at Guggenheim.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448472\" data-linked=\"Roku offers HBO in Roku Channel premium subscriptions\" data-tweet=\"$ROKU $T - Roku offers HBO in Roku Channel premium subscriptions https://seekingalpha.com/news/3448472-roku-offers-hbo-in-roku-channel-premium-subscriptions?source=tweet\" data-url=\"https://seekingalpha.com/news/3448472-roku-offers-hbo-in-roku-channel-premium-subscriptions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448470\" data-ts=\"1554391254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTT\" target=\"_blank\">OPTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448470-ocean-power-technologies-and-acteon-field-life-service-announce-collaborative-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Power Technologies and Acteon Field Life Service announce collaborative agreement</a></h4><ul><li>Ocean Power Technologies (<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='red'>-60.2%</font>) and Acteon Field Life Service Ltd have entered a <a href=\"https://seekingalpha.com/pr/17466897-ocean-power-technologies-acteon-field-life-service-announce-collaborative-agreement\" target=\"_blank\">non-exclusive MOU</a> to develop, explore and exploit mutual opportunities in the global oil and gas and renewable markets.</li><li>George H. Kirby, President and CEO: \u201cWe see a strong potential in this collaboration, where OPT\u2019s PowerBuoy® products and services and Acteon\u2019s integrated subsea services and solutions, coupled with its global network of facilities, personnel and market positioning, can provide significant value to our customers.\u201d</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448398-ocean-power-gives-back-gains-15m-public-offering\" target=\"_blank\">Ocean Power gives back gains after $15M public offering</a> (April 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448470\" data-linked=\"Ocean Power Technologies and Acteon Field Life Service announce collaborative agreement\" data-tweet=\"$OPTT - Ocean Power Technologies and Acteon Field Life Service announce collaborative agreement https://seekingalpha.com/news/3448470-ocean-power-technologies-and-acteon-field-life-service-announce-collaborative-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3448470-ocean-power-technologies-and-acteon-field-life-service-announce-collaborative-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448467\" data-ts=\"1554391049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOIEF\" target=\"_blank\">SOIEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448467-stolt-nielsenplus-6_1-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stolt-Nielsen +6.1% post Q1 results</a></h4><ul><li>Stolt-Nielsen (<a href='https://seekingalpha.com/symbol/SOIEF' title='Stolt-Nielsen Limited'>OTCPK:SOIEF</a>) reported <a href=\"https://ml-eu.globenewswire.com/Resource/Download/f65b6f63-5181-41a4-833d-a2c60646fc87\" target=\"_blank\">Q1</a> revenue decreased of 2.6% Y/Y to $501.95M.</li><li>Segment revenue: Tankers $312.42M (-2.5% Y/Y), Terminals $63.27M (+1.2% Y/Y), Tank containers $124.1M (-6.4% Y/Y) and Stolt Sea farm $25.38M (+7.3% Y/Y).</li><li>Q1 Overall margins: Gross <font color=\"red\">declined by 91 bps</font> to 17.87% and operating <font color=\"red\">declined 214 bps</font> to 8.52%, Adj. EBITDA <font color=\"green\">improved by 51 bps</font> to 21.73%.</li><li>Segment operating margin: Tankers <font color=\"green\">increased by 137 bps</font> to 4.97%; Terminals <font color=\"red\">declined by 1,267 bps</font> to 28.44%; Tank containers improved by 357 bps to 15.7%.</li><li>Stolt tankers joint service sailed-in time-charter index was 0.53, compared with 0.57 in the prior quarter.</li><li>At Stolthaven terminals tank capacity utilization was at 92.3% compared to 88.5% year ago</li><li>Stolt tank containers number of shipments were 29,160 (-8% Y/Y) whereas, Tank containers owned and leased at the end of the period were 39,462 (+7.6% Y/Y).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448384-stolt-nielsen-eps-0_13\" target=\"_blank\">Stolt-Nielsen EPS of $0.13</a> (Apr. 04 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448467\" data-linked=\"Stolt-Nielsen +6.1% post Q1 results\" data-tweet=\"$SOIEF - Stolt-Nielsen +6.1% post Q1 results https://seekingalpha.com/news/3448467-stolt-nielsenplus-6_1-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3448467-stolt-nielsenplus-6_1-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448466\" data-ts=\"1554390766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IR\" target=\"_blank\">IR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448466-ingersoll-rand-upped-to-buy-baml-premium-growth-looks-sustainable\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ingersoll-Rand upped to Buy at BAML as premium growth looks sustainable</a></h4><ul><li>Ingersoll-Rand (<a href='https://seekingalpha.com/symbol/IR' title='Ingersoll-Rand Plc'>IR</a> <font color=\"green\">+1.5%</font>) rises after BofA Merrill Lynch <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/19/04/13486553/bofa-upgrades-ingersoll-rand-says-premium-growth-appears-sustainable\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $130 price target, raised from $105, citing premium core earnings growth.</li><li>The U.S. non-residential construction cycle has room for growth through 2020 as the macro environment improves and with spending remaining below peak levels, and institutional construction spending has continued runway that will benefit IR, BAML Andrew Obin says.</li><li>\"While we recognize that the stock has been one of the best performers in the past few years, we see additional upside potential to IR over the coming year, as we think investors will likely be willing to pay up for premium organic growth, better EPS growth visibility and structurally higher service business,\" Obin writes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448466\" data-linked=\"Ingersoll-Rand upped to Buy at BAML as premium growth looks sustainable\" data-tweet=\"$IR - Ingersoll-Rand upped to Buy at BAML as premium growth looks sustainable https://seekingalpha.com/news/3448466-ingersoll-rand-upped-to-buy-baml-premium-growth-looks-sustainable?source=tweet\" data-url=\"https://seekingalpha.com/news/3448466-ingersoll-rand-upped-to-buy-baml-premium-growth-looks-sustainable\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448464\" data-ts=\"1554390400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYHT\" target=\"_blank\">TYHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448464-shineco-up-28-on-hemp-plan-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shineco up 28% on hemp plan in China</a></h4><ul><li>Nano cap Shineco (<a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a> <font color=\"green\">+28.4%</font>) is up on an 11x surge in volume in reaction to its <a href=\"https://seekingalpha.com/pr/17466811-shineco-inc-enters-strategic-cooperation-agreement-regional-peoples-government-construction\" target=\"_blank\">agreement </a>with the Xingshan People's Government of Hegang City of Heilongjiang Province to promote the development of an industrial hemp industry, including cultivation, harvesting, processing and fine extraction.</li><li>The parties will work together to develop a 3,295-acre cultivation site. The harvest from the first 82 acres should be available this year.</li><li>Shineco CEO Yuying Zhang says annual production should be 30 tons of CBD extract, 2,000 tons of industrial hemp, 500 tons of industrial hemp seed oil and 4,000 tons of hemp leaves (sounds bullish for a 3,295-acre plot).</li></ul><div class=\"tiny-share-widget\" data-id=\"3448464\" data-linked=\"Shineco up 28% on hemp plan in China\" data-tweet=\"$TYHT - Shineco up 28% on hemp plan in China https://seekingalpha.com/news/3448464-shineco-up-28-on-hemp-plan-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3448464-shineco-up-28-on-hemp-plan-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448463\" data-ts=\"1554390222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448463-cloud-stocks-fall-after-record-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloud stocks fall after record day</a></h4><ul><li>Cloud-related tech stocks retreat after yesterday's record high for S&amp;P 500 tech names.</li><li>Movers include ServiceNow (<a href='https://seekingalpha.com/symbol/NOW' title='ServiceNow, Inc.'>NOW</a> <font color='red'>-4.7%</font>), Zscaler (<a href='https://seekingalpha.com/symbol/ZS' title='Zscaler, Inc.'>ZS</a> <font color='red'>-6.4%</font>), Twilio (<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio Inc.'>TWLO</a> <font color='red'>-4.5%</font>), Workday (<a href='https://seekingalpha.com/symbol/WDAY' title='Workday, Inc.'>WDAY</a> <font color='red'>-5.4%</font>), Zendesk (<a href='https://seekingalpha.com/symbol/ZEN' title='Zendesk, Inc.'>ZEN</a> <font color='red'>-4.2%</font>), Atlassian (<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian Corporation Plc'>TEAM</a> <font color='red'>-4.2%</font>), and HubSpot (<a href='https://seekingalpha.com/symbol/HUBS' title='HubSpot, Inc.'>HUBS</a> <font color='red'>-3.2%</font>).</li><li>The tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) is <font color=\"red\">down 0.5%</font> while the Nasdaq dips <font color=\"red\">0.2%</font> and the S&amp;P 500 gains<font color=\"green\"> 0.12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448463\" data-linked=\"Cloud stocks fall after record day\" data-tweet=\"$NOW $ZS $TWLO - Cloud stocks fall after record day https://seekingalpha.com/news/3448463-cloud-stocks-fall-after-record-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3448463-cloud-stocks-fall-after-record-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448462\" data-ts=\"1554390179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448462-tonix-pharmaceuticals-and-recro-pharma-among-healthcare-gainers-aveo-pharmaceuticals-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix Pharmaceuticals and Recro Pharma among healthcare gainers; AVEO Pharmaceuticals and ReWalk Robotics among losers</a></h4><ul><li><b>Gainers: </b>Recro Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/REPH' title='Recro Pharma, Inc.'>REPH</a>) <font color=\"green\">+27%</font>. Shineco (NASDAQ:<a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a>) <font color=\"green\">+25%</font>. Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"green\">+16%</font>. Dynatronics (NASDAQ:<a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a>) <font color=\"green\">+10%</font>. AquaBounty Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a>) <font color=\"green\">+10%</font>.</li><li><b>Losers: </b>InspireMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a>) <font color=\"red\">-31%</font>. AVEO Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) <font color=\"red\">-28%</font>. Pulmatrix (NASDAQ:<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a>) <font color=\"red\">-24%</font>. ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a>) <font color=\"red\">-15%</font>. Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics Inc.'>ATOS</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448462\" data-linked=\"Tonix Pharmaceuticals and Recro Pharma among healthcare gainers; AVEO Pharmaceuticals and ReWalk Robotics among losers\" data-tweet=\"$REPH $TYHT $TNXP - Tonix Pharmaceuticals and Recro Pharma among healthcare gainers; AVEO Pharmaceuticals and ReWalk Robotics among losers https://seekingalpha.com/news/3448462-tonix-pharmaceuticals-and-recro-pharma-among-healthcare-gainers-aveo-pharmaceuticals-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3448462-tonix-pharmaceuticals-and-recro-pharma-among-healthcare-gainers-aveo-pharmaceuticals-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448452\" data-ts=\"1554389057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTT\" target=\"_blank\">QTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448452-qutoutiao-announces-pricing-of-upsized-follow-on-public-offering-of-ads\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qutoutiao announces pricing of upsized follow-on public offering of ADS</a></h4><ul><li>Qutoutiao (<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao Inc.'>QTT</a> <font color=\"red\">-2.3%</font>) <a href=\"https://seekingalpha.com/pr/17465880-qutoutiao-announces-pricing-upsized-follow-public-offering-american-depositary-shares\" target=\"_blank\">prices upsized</a> offering of ~3.327M ADSs by the company and ~6.672M ADSs by several shareholders at $10/ADS.</li><li>The Company will not receive any proceeds from the sale of ADSs by the Selling Shareholders.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448452\" data-linked=\"Qutoutiao announces pricing of upsized follow-on public offering of ADS\" data-tweet=\"$QTT - Qutoutiao announces pricing of upsized follow-on public offering of ADS https://seekingalpha.com/news/3448452-qutoutiao-announces-pricing-of-upsized-follow-on-public-offering-of-ads?source=tweet\" data-url=\"https://seekingalpha.com/news/3448452-qutoutiao-announces-pricing-of-upsized-follow-on-public-offering-of-ads\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448450\" data-ts=\"1554388604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVOP\" target=\"_blank\">EVOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448450-evo-payments-prices-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evo Payments prices share offering</a></h4><ul><li>EVO Payments (<a href='https://seekingalpha.com/symbol/EVOP' title='EVO Payments, Inc.'>EVOP</a> <font color=\"green\">+1.3%</font>) <a href=\"https://seekingalpha.com/pr/17466108-evo-payments-announces-pricing-offering-5000-000-shares-common-stock\" target=\"_blank\">prices</a> 5M shares of common stock at $26.50/share.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3447500-evo-payments-plans-5m-share-offering-class-common-stock\" target=\"_blank\">EVO Payments plans 5M-share offering of class A common stock</a> (April 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448450\" data-linked=\"Evo Payments prices share offering\" data-tweet=\"$EVOP - Evo Payments prices share offering https://seekingalpha.com/news/3448450-evo-payments-prices-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3448450-evo-payments-prices-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448447\" data-ts=\"1554388341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448447-citron-expects-shopify-to-crater\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron expects Shopify to crater</a></h4><ul> <li>Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify Inc.'>SHOP</a>) is <font color=\"red\">down 2.95%</font> after Citron Research takes aim at the stock with a short recommendation.</li> <li>Citron says a \"drastic change\" in the competitive and regulatory landscape will negatively impact the Shopify growth story, pointing to <a href=\"https://seekingalpha.com/symbol/SHOP?news=news-all\" target=\"_blank\">recent news</a> from Mailchimp, Square, Instagram and even Microsoft.</li> <li>The firm is so sure of its call that it plans to donate $200K to the Robin Hood Foundation if SHOP is trading over $200 in 12 months (SHOP was at $198.90 at last check). The official 12-month price target from Citron on SHOP is $100.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448447\" data-linked=\"Citron expects Shopify to crater\" data-tweet=\"$SHOP - Citron expects Shopify to crater https://seekingalpha.com/news/3448447-citron-expects-shopify-to-crater?source=tweet\" data-url=\"https://seekingalpha.com/news/3448447-citron-expects-shopify-to-crater\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448446\" data-ts=\"1554388247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448446-natural-gas-inventory-builds-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory builds more than expected</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+</strong><strong>23</strong> <strong>Bcf</strong> vs. +10 Bcf consensus, -36 Bcf last week.</li><li>Futures <font color=\"red\">-0.19%</font> to $2.672.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3448446\" data-linked=\"Natural gas inventory builds more than expected\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory builds more than expected https://seekingalpha.com/news/3448446-natural-gas-inventory-builds-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3448446-natural-gas-inventory-builds-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448443\" data-ts=\"1554388045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KN\" target=\"_blank\">KN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448443-knowles-working-on-activist-investor-defense-dealreporter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Knowles working on activist investor defense - DealReporter</a></h4><ul><li>Knowles (NYSE:<a href='https://seekingalpha.com/symbol/KN' title='Knowles Corporation'>KN</a>) is working with JPMorgan on defense against activist investors Caligan Partners and Falcon Edge Capital, according to DealReporter sources.</li><li>The activists have nominated two board members and asked the company to consider strategic alternatives.</li><li>Knowles was reportedly receptive to the activist approach, but talks hit a \"key sticking point\" when Knowles wanted a two-year standstill agreement.</li><li>Knowles shares are <font color=\"green\">up 1.1%</font> to $17.82.</li><li>Post updated to add more details.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448443\" data-linked=\"Knowles working on activist investor defense - DealReporter\" data-tweet=\"$KN - Knowles working on activist investor defense - DealReporter https://seekingalpha.com/news/3448443-knowles-working-on-activist-investor-defense-dealreporter?source=tweet\" data-url=\"https://seekingalpha.com/news/3448443-knowles-working-on-activist-investor-defense-dealreporter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448438\" data-ts=\"1554387678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LILA\" target=\"_blank\">LILA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448438-liberty-latin-americaplus-2_5-macquarie-raise-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liberty Latin America +2.5% with Macquarie raise to Outperform</a></h4><ul>   <li>Liberty Latin America (NASDAQ:<a href='https://seekingalpha.com/symbol/LILA' title='Liberty Latin America Ltd.'>LILA</a>) is <font color=\"green\">up 2.5%</font> following a boost to Outperform by Macquarie.</li>    <li>The stock is a \"misunderstood, underappreciated name with a unique mix of cable/mobile assets,\" analyst Amy Yong says, noting potential upside in its multiple and earnings (due for report on May 7). \"We are incrementally bullish\" on \"signs of operational momentum, an inflection in case and ongoing consolidation.\" (h/t Bloomberg)</li>    <li>She has a price target of $26, implying 26% upside.</li><li>It's <a href=\"https://seekingalpha.com/symbol/LILA/earnings/estimates\" target=\"_blank\">expected to report</a> EPS of $0.07 on revenues of $967.4M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448438\" data-linked=\"Liberty Latin America +2.5% with Macquarie raise to Outperform\" data-tweet=\"$LILA $LILAB $LILAK - Liberty Latin America +2.5% with Macquarie raise to Outperform https://seekingalpha.com/news/3448438-liberty-latin-americaplus-2_5-macquarie-raise-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3448438-liberty-latin-americaplus-2_5-macquarie-raise-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448433\" data-ts=\"1554386824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448433-leading-cancer-center-to-evaluate-sellas-galinpepimut-s-in-mesothelioma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leading cancer center to evaluate SELLAS&#39; galinpepimut-S in mesothelioma</a></h4><ul><li>Memorial Sloan Kettering Cancer Center will <a href=\"https://seekingalpha.com/pr/17466654-sellas-life-sciences-group-world-renowned-cancer-center-study-galinpepimut-s-gps-combination\" target=\"_blank\">conduct </a>an open-label Phase 1 clinical trial evaluating the combination of SELLAS Life Sciences' (<a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color=\"green\">+4%</font>) galinpepimut-S &#40;GPS&#41; and Bristol-Myers Squibb's (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.2%</font>) Opdivo (nivolumab) in patients with malignant pleural mesothelioma &#40;MPM&#41;.</li><li>The objective is to determine if the combination can produce antitumor immune responses and meaningful clinical activity in MPM patients with macroscopic disease compared to Opdivo alone in historically compatible populations.</li><li>In a Phase 2 study completed in 2017, GPS administered as maintenance therapy after first-line tumor-debulking multimodality treatment, increased median survival almost 4 1/2 months (22.8 months vs. 18.3 months) with sustained immune responses.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448433\" data-linked=\"Leading cancer center to evaluate SELLAS&#39; galinpepimut-S in mesothelioma\" data-tweet=\"$SLS $BMY - Leading cancer center to evaluate SELLAS&#39; galinpepimut-S in mesothelioma https://seekingalpha.com/news/3448433-leading-cancer-center-to-evaluate-sellas-galinpepimut-s-in-mesothelioma?source=tweet\" data-url=\"https://seekingalpha.com/news/3448433-leading-cancer-center-to-evaluate-sellas-galinpepimut-s-in-mesothelioma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448426\" data-ts=\"1554386269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448426-gun-stocks-extend-on-yesterdays-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gun stocks extend on yesterday&#39;s gains</a></h4><ul> <li>Firearm stocks are higher in morning trading to follow on yesterday's rally off fresh gun data.</li> <li>KeyBanc notes gun demand as indicated by background checks was strong than anticipated against a tough comparison from a year ago (Parkland shooting anniversary).</li> <li>On watch: Sturm, Ruger (<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company, Inc.'>RGR</a> <font color='green'>+1.1%</font>), Vista Outdoor (<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor Inc.'>VSTO</a> <font color='green'>+2.9%</font>) and American Outdoor Brands (<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='green'>+2.8%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448204-firearm-related-stocks-gain-background-checks-move-higher\" target=\"_blank\">Firearm-related stocks gain after background checks move higher</a> (April 3)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448426\" data-linked=\"Gun stocks extend on yesterday&#39;s gains\" data-tweet=\"$RGR $VSTO $AOBC - Gun stocks extend on yesterday&#39;s gains https://seekingalpha.com/news/3448426-gun-stocks-extend-on-yesterdays-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3448426-gun-stocks-extend-on-yesterdays-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448424\" data-ts=\"1554385907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETTX\" target=\"_blank\">ETTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448424-entasis-launches-late-stage-study-of-antibiotic-combo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Entasis launches late-stage study of antibiotic combo</a></h4><ul><li>Entasis Therapeutics (<a href='https://seekingalpha.com/symbol/ETTX' title='Entasis Therapeutics'>ETTX</a>) <a href=\"https://seekingalpha.com/pr/17466573-entasis-therapeutics-initiates-global-phase-3-pivotal-trial-etx2514sul-patients-carbapenem\" target=\"_blank\">initiates </a>a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03894046?term=NCT03894046&amp;rank=1\" target=\"_blank\">ATTACK</a>, evaluating ETX2514SUL, a fixed-dose combination of its broad-spectrum β-lactamase inhibitor ETX2514 with sulbactam, for the treatment of patients with pneumonia and bloodstream infections caused by carbapenem-resistant <em>Acinetobacter baumannii,</em><em> </em>a Gram-negative bacterium.</li><li>The company believes that this single 300-subject study should be sufficient to support marketing applications in the U.S. and Europe.</li><li>An application in China is also possible via its partnership with Zia Lab (<a href='https://seekingalpha.com/symbol/ZLAB' title='Zai Lab Limited'>ZLAB</a> <font color=\"green\">+1.3%</font>).</li><li>ETX2514SUL has Fast Track and Qualified Infectious Disease Product status in the U.S.</li><li>ETTX is up <font color=\"green\">2%</font> in early trade.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448424\" data-linked=\"Entasis launches late-stage study of antibiotic combo\" data-tweet=\"$ETTX $ZLAB - Entasis launches late-stage study of antibiotic combo https://seekingalpha.com/news/3448424-entasis-launches-late-stage-study-of-antibiotic-combo?source=tweet\" data-url=\"https://seekingalpha.com/news/3448424-entasis-launches-late-stage-study-of-antibiotic-combo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448421\" data-ts=\"1554385653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448421-commscope-closes-arris-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CommScope closes Arris acquisition</a></h4><ul>   <li>CommScope (<a href=\"http://seekingalpha.com/symbol/COMM\" target=\"_blank\">COMM</a> <font color=\"green\">+2.6%</font>) has <a href=\"https://seekingalpha.com/pr/17466879-commscope-set-shape-communications-connectivity-networks-future-completion-arris-acquisition\" target=\"_blank\">completed its acquisition</a> of Arris (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRS' title='ARRIS International plc'>ARRS</a>), a $7.4B deal including debt that more than doubles CommScope's size.</li>    <li>The two came to a deal in November, news that goosed Arris stock.</li>    <li>CommScope is expecting 30%-plus accretion to adjusted EPS in the first full year after the closing, and annual cost synergies of at least $150M within three years.</li>    <li>It also expects nearly $1B of cash flow from operations in the first full year, and will use free cash flow to \"aggressively\" pay down debt.</li>    <li>As part of financing the deal, Carlyle Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CG' title='The Carlyle Group L.P.'>CG</a>) has reestablished a position in CommScope via a $1B minority investment; Carlyle's Daniel Akerson and Campbell Dyer have now joined the CommScope board.</li>    <li>CommScope is set to release earnings on May 9; with the acquisition closing after the quarter's end, those results will come on a stand-alone basis, but the company will issue guidance on a combined basis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448421\" data-linked=\"CommScope closes Arris acquisition\" data-tweet=\"$ARRS $CG $COMM - CommScope closes Arris acquisition https://seekingalpha.com/news/3448421-commscope-closes-arris-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3448421-commscope-closes-arris-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448420\" data-ts=\"1554385316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTXS\" target=\"_blank\">CTXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448420-citrixminus-1_2-not-considering-sale-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citrix -1.2% not considering a sale - The Deal</a></h4><ul><li>Citrix Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CTXS' title='Citrix Systems, Inc.'>CTXS</a>) <font color=\"red\">drops 1.2% </font>after TheDeal.com sources say the company isn't pursuing a potential sale, contrary to <a href=\"https://seekingalpha.com/news/3448189-citrix-hires-goldman-potential-sale-nyp\" target=\"_blank\">yesterday's report</a> from the <em>New York Post</em>.</li><li>Source: Bloomberg First Word.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448420\" data-linked=\"Citrix -1.2% not considering a sale - The Deal\" data-tweet=\"$CTXS - Citrix -1.2% not considering a sale - The Deal https://seekingalpha.com/news/3448420-citrixminus-1_2-not-considering-sale-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3448420-citrixminus-1_2-not-considering-sale-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448419\" data-ts=\"1554385274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIXX\" target=\"_blank\">FIXX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448419-homology-medicines-on-go-study-of-gene-therapy-for-pku\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Homology Medicines on go with study of gene therapy for PKU</a></h4><ul><li>The FDA has <a href=\"https://seekingalpha.com/pr/17466382-homology-medicines-announces-fda-clearance-investigational-new-drug-application-hmiminus-102\" target=\"_blank\">signed off</a> on a Phase 1/2 clinical trial, pheNIX, evaluating Homology Medicines' (<a href='https://seekingalpha.com/symbol/FIXX' title='Homology Medicines, Inc.'>FIXX</a> <font color=\"green\">+0.4%</font>) gene therapy candidate HMI-102 in adults with a rare inherited disorder called phenylketonuria &#40;PKU&#41;, referred to as an inborn error of metabolism.</li><li>The open-label study will assess the safety and efficacy of escalating doses of the one-time gene therapy in patients with classic PKU (due to a deficiency of an enzyme called phenylalanine hydroxylase).</li><li>PKU-related tickers: BioMarin Pharmaceutical (<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color=\"green\">+0.6%</font>); Codexis (<a href='https://seekingalpha.com/symbol/CDXS' title='Codexis, Inc.'>CDXS</a> <font color=\"red\">-1.3%</font>); Retrophin (<a href='https://seekingalpha.com/symbol/RTRX' title='Retrophin, Inc.'>RTRX</a> <font color=\"red\">-0.5%</font>); Synlogic (<a href='https://seekingalpha.com/symbol/SYBX' title='Synlogic, Inc.'>SYBX</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448419\" data-linked=\"Homology Medicines on go with study of gene therapy for PKU\" data-tweet=\"$FIXX $BMRN $CDXS - Homology Medicines on go with study of gene therapy for PKU https://seekingalpha.com/news/3448419-homology-medicines-on-go-study-of-gene-therapy-for-pku?source=tweet\" data-url=\"https://seekingalpha.com/news/3448419-homology-medicines-on-go-study-of-gene-therapy-for-pku\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448414\" data-ts=\"1554384720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDD\" target=\"_blank\">PDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448414-pinduoduominus-2_5-on-ft-cash-burn-criticism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinduoduo -2.5% on FT cash burn criticism</a></h4><ul><li>Pinduoduo (NASDAQ:<a href='https://seekingalpha.com/symbol/PDD' title='Pinduoduo Inc.'>PDD</a>) shares <font color=\"red\">drop 2.5%</font> after an<a href=\"https://www.ft.com/content/e1d8d51a-4fac-11e9-9c76-bf4a0ce37d49\" target=\"_blank\"> FT article </a>criticizing the company's cash burn. PDD spent $1.50 for every dollar of sales in Q4.</li><li>Sales and marketing expenses increased 8x Y/Y RMB 6B, erasing the RMB 5.65B in revenue. Pinduoduo says the spending was needed for growth and MAUs did double Y/Y in the quarter to 273M.</li><li>Pinduoduo listed in September with a $20B valuation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448414\" data-linked=\"Pinduoduo -2.5% on FT cash burn criticism\" data-tweet=\"$PDD - Pinduoduo -2.5% on FT cash burn criticism https://seekingalpha.com/news/3448414-pinduoduominus-2_5-on-ft-cash-burn-criticism?source=tweet\" data-url=\"https://seekingalpha.com/news/3448414-pinduoduominus-2_5-on-ft-cash-burn-criticism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448410\" data-ts=\"1554384503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVG\" target=\"_blank\">PVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448410-pretium-resources-sees-strong-economics-for-brucejack-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pretium Resources sees strong economics for Brucejack mine</a></h4><ul><li>Pretium Resources (NYSE:<a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc.'>PVG</a>) <font color=\"red\">-1.9%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17466250-pretium-resources-inc-continued-robust-economics-brucejack-mine-confirmed-updated-mineral\" target=\"_blank\">releasing a 14-year plan</a> for its Brucejack mine in British Columbia, which the company expects will produce 525K oz./year of gold over the first 10 years and 440K/year over a 14-year mine life.</li><li>PVG forecasts Brucejack's average all-in sustaining costs of $535/oz. of gold sold over the first 10 years and average life of mine AISC of $539/oz.</li><li>At $1,300 gold, Brucejack now  has an estimated after-tax net present value at a 5% discount rate of $2.59B over a 14-year mine life, a significant increase from the 2017 estimated net present value at a 5% discount rate of $2.1B, PVG says.</li><li>Brucejack's proven and probable reserves are listed at 6.4M oz. of gold.</li><li>PVG also says it expects to meet its 2019 gold production guidance of 390K-420K oz. and the planned production ramp-up from 2,700 mt/day to 3,800 mt/day over the course of the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448410\" data-linked=\"Pretium Resources sees strong economics for Brucejack mine\" data-tweet=\"$PVG - Pretium Resources sees strong economics for Brucejack mine https://seekingalpha.com/news/3448410-pretium-resources-sees-strong-economics-for-brucejack-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3448410-pretium-resources-sees-strong-economics-for-brucejack-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448407\" data-ts=\"1554384292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448407-tnxp-and-mtfb-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TNXP and MTFB among premarket gainers</a></h4><ul><li>Shineco (NASDAQ:<a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a>) <font color=\"green\">+39%</font>.</li><li>Recro Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/REPH' title='Recro Pharma, Inc.'>REPH</a>) <font color=\"green\">+20%</font> on <a href=\"https://seekingalpha.com/news/3448257-recro-pharma-17-percent-reorg-plan-bullish-outlook\" target=\"_blank\">reorganization</a> plan.</li><li>Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"green\">+19%</font> on <a href=\"https://seekingalpha.com/news/3448379-tonix-pharma-expand-tnxminus-102-sl-phase-3-program-shares-plus-21-percent-premarket\" target=\"_blank\">expanding</a> TNX-102 SL phase 3 program.</li><li>Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"green\">+18%</font>.</li><li>MYOS RENS Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology Inc.'>MYOS</a>) <font color=\"green\">+14%</font> on <a href=\"https://seekingalpha.com/pr/17466257-myos-rens-technology-signs-distribution-agreement-national-sales-associates-llc\" target=\"_blank\">signing</a> agreement with National Sales Associates.</li><li>Motif Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/MTFB' title='Motif Bio plc'>MTFB</a>) <font color=\"green\">+11%</font> ahead of <a href=\"https://seekingalpha.com/news/3448404-motif-bio-15-percent-premarket-ahead-inclaprim-presentations\" target=\"_blank\">Inclaprim</a> presentations.</li><li>TheStreet (NASDAQ:<a href='https://seekingalpha.com/symbol/TST' title='TheStreet, Inc.'>TST</a>) <font color=\"green\">+6%</font> on cash <a href=\"https://seekingalpha.com/news/3448239-thestreet-plus-5_2-percent-cash-distribution-1minus-10-reverse-split\" target=\"_blank\">distribution</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448407\" data-linked=\"TNXP and MTFB among premarket gainers\" data-tweet=\"$TYHT $REPH $TNXP - TNXP and MTFB among premarket gainers https://seekingalpha.com/news/3448407-tnxp-and-mtfb-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448407-tnxp-and-mtfb-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448404\" data-ts=\"1554384064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTFB\" target=\"_blank\">MTFB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448404-motif-bio-up-15-premarket-ahead-of-inclaprim-presentations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Motif Bio up 15% premarket ahead of Inclaprim presentations</a></h4><ul><li>Nano cap Motif Bio plc (NASDAQ:<a href='https://seekingalpha.com/symbol/MTFB' title='Motif Bio plc'>MTFB</a>) perks up <font color=\"green\">15%</font> premarket on average volume in apparent response to <a href=\"https://seekingalpha.com/pr/17466189-motif-bio-present-iclaprim-data-eccmid-2019\" target=\"_blank\">upcoming abstracts</a> on iclaprim to be presented at ECCMID in Amsterdam starting next Saturday, April 13.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448404\" data-linked=\"Motif Bio up 15% premarket ahead of Inclaprim presentations\" data-tweet=\"$MTFB - Motif Bio up 15% premarket ahead of Inclaprim presentations https://seekingalpha.com/news/3448404-motif-bio-up-15-premarket-ahead-of-inclaprim-presentations?source=tweet\" data-url=\"https://seekingalpha.com/news/3448404-motif-bio-up-15-premarket-ahead-of-inclaprim-presentations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448402\" data-ts=\"1554383895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448402-tsla-and-aveo-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TSLA and AVEO among premarket losers</a></h4><ul><li>Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"red\">-54%</font>.</li><li>AVEO Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) <font color=\"red\">-30%</font> after <a href=\"https://seekingalpha.com/news/3448308-aveo-pharma-24-percent-pricing-equity-offering\" target=\"_blank\">pricing</a> equity offering.</li><li>InspireMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a>) <font color=\"red\">-29%</font> on <a href=\"https://seekingalpha.com/news/3448306-inspiremd-30-percent-pricing-stock-offering\" target=\"_blank\">pricing</a> stock offering.</li><li>Pulmatrix (NASDAQ:<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a>) <font color=\"red\">-26%</font> on <a href=\"https://seekingalpha.com/news/3448309-pulmatrix-24-percent-pricing-equity-offering\" target=\"_blank\">pricing</a> equity offering.</li><li>Office Depot (NASDAQ:<a href='https://seekingalpha.com/symbol/ODP' title='Office Depot, Inc.'>ODP</a>) <font color=\"red\">-14%</font> on announcing <a href=\"https://seekingalpha.com/news/3448325-office-depot-warns-q1-revenue-shortfall\" target=\"_blank\">preliminary</a> Q1 results.</li><li>ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a>) <font color=\"red\">-11%</font> on <a href=\"https://seekingalpha.com/news/3448312-rewalk-robotics-4-percent-stock-offering\" target=\"_blank\">stock offering</a>.</li><li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <font color=\"red\">-10%</font> after <a href=\"https://seekingalpha.com/pr/17466122-tesla-q1-2019-vehicle-production-and-deliveries\" target=\"_blank\">deliveries</a> tumble 31%.</li><li>Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"red\">-7%</font>.</li><li>Sangamo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3448373-sangamo-6-percent-pricing-stock-offering\" target=\"_blank\">pricing</a> stock offering.</li><li>Baozun (NASDAQ:<a href='https://seekingalpha.com/symbol/BZUN' title='Baozun Inc.'>BZUN</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/pr/17466316-baozun-announces-proposed-offering-us-225-million-convertible-senior-notes\" target=\"_blank\">announcing</a> proposed convertible debt offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448402\" data-linked=\"TSLA and AVEO among premarket losers\" data-tweet=\"$OPTT $AVEO $NSPR - TSLA and AVEO among premarket losers https://seekingalpha.com/news/3448402-tsla-and-aveo-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448402-tsla-and-aveo-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448399\" data-ts=\"1554383711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448399-facebookplus-1_6-guggenheim-raises-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook +1.6% as Guggenheim raises to Buy</a></h4><ul>   <li>Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook, Inc.'>FB</a>) is <font color=\"green\">up 1.6%</font> premarket after an upgrade to Buy at Guggenheim, from Neutral.</li>    <li>The firm's stance comes for a reason unsurprising to bulls: It thinks investors will continue with patience for increasing risk from privacy issues that continue to show up in headlines.</li>    <li>The firm's Michael Morris boosted his price target to $200 from $175, implying 15.2% upside.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448185-bloomberg-facebook-user-records-stored-publicly-aws-servers\" target=\"_blank\">Bloomberg: Facebook user records stored publicly on AWS servers</a> (Apr. 03 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448399\" data-linked=\"Facebook +1.6% as Guggenheim raises to Buy\" data-tweet=\"$FB - Facebook +1.6% as Guggenheim raises to Buy https://seekingalpha.com/news/3448399-facebookplus-1_6-guggenheim-raises-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3448399-facebookplus-1_6-guggenheim-raises-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448398\" data-ts=\"1554383693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTT\" target=\"_blank\">OPTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448398-ocean-power-gives-back-gains-after-15m-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Power gives back gains after $15M public offering</a></h4><ul><li>Up one day, down another. After <font color=\"green\">soaring 55%</font> in yesterday's session due to a contract announcement, Ocean Power (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) is pointing to opening <font color=\"red\">losses of 61%</font>.</li><li>The company is <a href=\"https://seekingalpha.com/pr/17466861-ocean-power-technologies-inc-prices-15000-000-public-offering\" target=\"_blank\">selling</a> 4.29M shares at $3.50 in a public offering, with gross proceeds of approximately $15M before deducting underwriting discounts, commissions and other offering expenses.</li><li>The common warrants will have an exercise price of $3.85 and pre-funded warrants will have a purchase price of $3.49 per share. The offering is expected to close on April 8.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448398\" data-linked=\"Ocean Power gives back gains after $15M public offering\" data-tweet=\"$OPTT - Ocean Power gives back gains after $15M public offering https://seekingalpha.com/news/3448398-ocean-power-gives-back-gains-after-15m-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3448398-ocean-power-gives-back-gains-after-15m-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448390\" data-ts=\"1554382891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEO\" target=\"_blank\">ABEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448390-abeonas-abominus-101-fast-trackd-for-mps-iiib-shares-up-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abeona&#39;s ABO-101 Fast Track&#39;d for MPS IIIB; shares up 5% premarket</a></h4><ul><li>The FDA has <a href=\"https://seekingalpha.com/pr/17466619-abeona-therapeutics-receives-fda-fast-track-designation-abominus-101-treatment-sanfilippo\" target=\"_blank\">granted</a> Fast Track designation to Abeona Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) ABO-101, the one-time gene therapy for Sanfilippo syndrome type B (MPS IIIB).</li><li>ABO-101 is designed to deliver a functional copy of the NAGLU gene to the central nervous system and peripheral tissues.</li><li>Fast Track status provides for more frequent interaction with the FDA review team and a rolling review of the marketing application.</li><li>Shares are up <font color=\"green\">5%</font> premarket.</li>         </ul><div class=\"tiny-share-widget\" data-id=\"3448390\" data-linked=\"Abeona&#39;s ABO-101 Fast Track&#39;d for MPS IIIB; shares up 5% premarket\" data-tweet=\"$ABEO - Abeona&#39;s ABO-101 Fast Track&#39;d for MPS IIIB; shares up 5% premarket https://seekingalpha.com/news/3448390-abeonas-abominus-101-fast-trackd-for-mps-iiib-shares-up-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3448390-abeonas-abominus-101-fast-trackd-for-mps-iiib-shares-up-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448386\" data-ts=\"1554382627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448386-pareteumplus-5-on-record-march-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum +5% on record March sales</a></h4><ul><li>Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <a href=\"https://seekingalpha.com/pr/17466374-pareteum-achieves-100-million-new-sales-agreements-march\" target=\"_blank\">announces</a> achieving a record $100M in newly signed 36MCRB agreements during March.</li><li>The second half of March contributed $80M to the company's 36-month contractual revenue backlog.</li><li>TEUM shares are <font color=\"green\">up 5.3%</font> pre-market to $5.15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448386\" data-linked=\"Pareteum +5% on record March sales\" data-tweet=\"$TEUM - Pareteum +5% on record March sales https://seekingalpha.com/news/3448386-pareteumplus-5-on-record-march-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3448386-pareteumplus-5-on-record-march-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448381\" data-ts=\"1554382192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIO\" target=\"_blank\">NIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448381-baml-removes-bear-call-on-nio\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML removes bear call on Nio</a></h4><ul> <li>Bank of America Merrill Lynch upgrades Nio (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) to a Neutral rating from Underperform after factoring in the Chinese EV automaker's deliveries update.</li> <li>\"While 2Q19 shipment may not be robust, we believe orders received in 2Q19 are better than 1Q19,\" notes the firm.</li> <li>The BAML analyst team expects volume sales to grow sequentially and calls Nio's current valuation of 1.2X EV/sales a \"fair\" level.</li><li>The firm assigns a price objective of $6.20 to Nio.</li><li>NIO <font color=\"green\">+2.55%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448371-nio-plus-3-percent-amid-tesla-tumble\" target=\"_blank\">Nio +3% amid Tesla tumble</a> (April 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448381\" data-linked=\"BAML removes bear call on Nio\" data-tweet=\"$NIO - BAML removes bear call on Nio https://seekingalpha.com/news/3448381-baml-removes-bear-call-on-nio?source=tweet\" data-url=\"https://seekingalpha.com/news/3448381-baml-removes-bear-call-on-nio\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448379\" data-ts=\"1554381912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448379-tonix-pharma-to-expand-tnxminus-102-sl-phase-3-program-sharesplus-21-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix Pharma to expand TNX-102 SL phase 3 program; shares +21% premarket</a></h4><ul><li>Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <a href=\"https://seekingalpha.com/pr/17466442-tonix-pharmaceuticals-plans-expand-tnxminus-102-sl-phase-3-program-beyond-ptsd-include\" target=\"_blank\">expands</a> TNX-102 SL 5.6 mg program beyond posttraumatic stress disorder &#40;PTSD&#41; to include Phase 3 development for TNX-102 SL in fibromyalgia.</li>     <li>A lower dose of TNX-102 SL (2.8 mg) taken daily at bedtime was studied previously in fibromyalgia in a Phase 2 study and a Phase 3 study.</li><li>Both studies showed clinical benefits especially in the quality of sleep improvement, however, primary analyses on pain reduction were not statistically significant.</li><li>Additional data developed by Tonix in the PTSD program showed that TNX-102 SL 5.6 mg (2 x 2.8 mg tablets) demonstrated acceptable tolerability with additional clinical benefit in pain reduction. There were no serious and/or adverse events reported.</li>  <li>The registration will be supported by two positive Phase 3 studies, and the long-term safety exposure data from the PTSD program may support the fibromyalgia NDA.</li><li>Shares are up <font color=\"green\">21%</font> premarket.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3448379\" data-linked=\"Tonix Pharma to expand TNX-102 SL phase 3 program; shares +21% premarket\" data-tweet=\"$TNXP - Tonix Pharma to expand TNX-102 SL phase 3 program; shares +21% premarket https://seekingalpha.com/news/3448379-tonix-pharma-to-expand-tnxminus-102-sl-phase-3-program-sharesplus-21-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3448379-tonix-pharma-to-expand-tnxminus-102-sl-phase-3-program-sharesplus-21-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448378\" data-ts=\"1554381773\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTN\" target=\"_blank\">MTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448378-macquarie-cools-on-vail-resorts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macquarie cools on Vail Resorts</a></h4><ul> <li>Macquarie drops Vail Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MTN' title='Vail Resorts, Inc.'>MTN</a>) to a Neutral rating after having the ski resort operator set at Outperform.</li> <li>The firm reels in its price target on Vail to $240 from $250, giving shares a little bit of room to run still.</li> <li>Shares of Vail are <font color=\"red\">down 0.31%</font> in premarket trading to $220.93.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448378\" data-linked=\"Macquarie cools on Vail Resorts\" data-tweet=\"$MTN - Macquarie cools on Vail Resorts https://seekingalpha.com/news/3448378-macquarie-cools-on-vail-resorts?source=tweet\" data-url=\"https://seekingalpha.com/news/3448378-macquarie-cools-on-vail-resorts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448375\" data-ts=\"1554381552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETSY\" target=\"_blank\">ETSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448375-etsyplus-1-on-canaccord-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Etsy +1% on Canaccord confidence</a></h4><ul> <li>Etsy (NASDAQ:<a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a>) <font color=\"green\">gains 1.0%</font> in premarket action after Canaccord Genuity jumps in with a <a href=\"https://www.cnbc.com/2019/04/04/calls-of-the-day-facebook-micron-disney-more.html\" target=\"_blank\">Buy rating</a>.</li> <li>The analyst team thinks Etsy has the \"special value proposition\" needed for an online retailer to prosper amid the Amazon domination. Etsy's new management team is given credit for bringing the platform closer to best-in-class peers.</li> <li>Canaccord's call on Etsy arrives with shares already up 46% YTD and 144% over the last 52 weeks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448375\" data-linked=\"Etsy +1% on Canaccord confidence\" data-tweet=\"$ETSY - Etsy +1% on Canaccord confidence https://seekingalpha.com/news/3448375-etsyplus-1-on-canaccord-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3448375-etsyplus-1-on-canaccord-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448374\" data-ts=\"1554381459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448374-tonix-up-22-premarket-on-expansion-of-tonmya-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix up 22% premarket on expansion of Tonmya program</a></h4><ul><li>Nano cap Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) has <a href=\"https://seekingalpha.com/pr/17466442-tonix-pharmaceuticals-plans-expand-tnxminus-102-sl-phase-3-program-beyond-ptsd-include\" target=\"_blank\">expanded</a> its Phase 3 development program for lead candidate Tonyma (cyclobenzaprine hydrochloride) beyond posttraumatic stress disorder &#40;PTSD&#41; into <a href=\"https://www.mayoclinic.org/diseases-conditions/fibromyalgia/symptoms-causes/syc-20354780\" target=\"_blank\">fibromyalgia</a>, a disorder of unknown cause characterized by widespread musculoskeletal pain and other issues.</li><li>Previous Phase 2 and Phase 3 studies assessing a 2.8 mg dose taken at night showed a treatment benefit in terms of improved quality of sleep but not pain reduction.</li><li>The company says a new Phase 3 study will evaluate the safety and efficacy of a 5.6 mg dose. The submission of the final protocol to the FDA is next up.</li><li>Tonmya is a non-opioid centrally acting analgesic.</li><li>Shares are up <font color=\"green\">22%</font> premarket on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448374\" data-linked=\"Tonix up 22% premarket on expansion of Tonmya program\" data-tweet=\"$TNXP - Tonix up 22% premarket on expansion of Tonmya program https://seekingalpha.com/news/3448374-tonix-up-22-premarket-on-expansion-of-tonmya-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3448374-tonix-up-22-premarket-on-expansion-of-tonmya-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448373\" data-ts=\"1554381190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448373-sangamo-down-6-on-pricing-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo down 6% on pricing stock offering</a></h4><ul> <li>Sangamo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>) <a href=\"https://seekingalpha.com/pr/17466568-sangamo-therapeutics-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices</a> its public offering of 11M common shares at $11.50 per share, for gross proceeds of ~$126.5M.</li><li>Underwriters over-allotment is an additional 1.65M shares.</li>                  <li>Net proceeds will be used for working capital and other general corporate purposes.</li><li>Closing date is April 8.</li><li>Shares are down <font color=\"red\">6%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448226-sangamo-5-percent-hours-equity-offering\" target=\"_blank\">Sangamo down 5% after hours on equity offering</a> (April 3)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448373\" data-linked=\"Sangamo down 6% on pricing stock offering\" data-tweet=\"$SGMO - Sangamo down 6% on pricing stock offering https://seekingalpha.com/news/3448373-sangamo-down-6-on-pricing-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3448373-sangamo-down-6-on-pricing-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448371\" data-ts=\"1554381133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIO\" target=\"_blank\">NIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448371-nioplus-3-amid-tesla-tumble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nio +3% amid Tesla tumble</a></h4><ul> <li>Nio (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) is <font color=\"green\">up 3.35%</font> in premarket trading to $5.47</li> <li>It's not the first time that shares of Nio have moved higher on a day that Tesla was tanking.</li> <li>Despite today's bump, Nio trades about 60% below its 52-week high and has been facing some sharp questions of its own.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448322-tesla-minus-8-percent-analysts-dig\" target=\"_blank\">Tesla -8% as analysts dig in</a> (April 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448371\" data-linked=\"Nio +3% amid Tesla tumble\" data-tweet=\"$NIO - Nio +3% amid Tesla tumble https://seekingalpha.com/news/3448371-nioplus-3-amid-tesla-tumble?source=tweet\" data-url=\"https://seekingalpha.com/news/3448371-nioplus-3-amid-tesla-tumble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448366\" data-ts=\"1554380656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESTC\" target=\"_blank\">ESTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448366-elastic-gains-on-overweight-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elastic gains on Overweight start</a></h4><ul><li>KeyBanc starts Elastic (NYSE:<a href='https://seekingalpha.com/symbol/ESTC' title='Elastic N.V.'>ESTC</a>) at Overweight with a target of $102, implying a 23% upside.</li><li>Elastic shares had a bumpy day yesterday as the IPO lockup expired and made 62.5M shares available (90% of outstanding).</li><li>ESTC is <font color=\"green\">up 0.9%</font> pre-market to $83.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448366\" data-linked=\"Elastic gains on Overweight start\" data-tweet=\"$ESTC - Elastic gains on Overweight start https://seekingalpha.com/news/3448366-elastic-gains-on-overweight-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3448366-elastic-gains-on-overweight-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448363\" data-ts=\"1554380305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNGX\" target=\"_blank\">SNGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448363-soligenix-nabs-new-patent-in-u-s-shares-up-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soligenix nabs new patent in U.S.; shares up 10% premarket</a></h4><ul><li>The USPTO will <a href=\"https://seekingalpha.com/pr/17466378-soligenix-receives-us-patent-dusquetide-related-analogs\" target=\"_blank\">issue</a> Soligenix (NASDAQ:<a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a>) new patent titled \"Novel Peptides for Treating and Preventing Immune-Related Disorders, Including Treating and Preventing Infection by Modulating Innate Immunity\" on April 9.</li><li>The new patent claims composition of matter for novel innate defense regulator &#40;IDR&#41; analogs, expanding patent protection to more diverse analog structures. Therapeutic use claims in oral mucositis, colitis, and infectious disease, both alone and in conjunction with antibiotics, will also issue.</li> <li>The composition of matter patents are generally valid until 2028.</li><li>Shares are up <font color=\"green\">10%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448363\" data-linked=\"Soligenix nabs new patent in U.S.; shares up 10% premarket\" data-tweet=\"$SNGX - Soligenix nabs new patent in U.S.; shares up 10% premarket https://seekingalpha.com/news/3448363-soligenix-nabs-new-patent-in-u-s-shares-up-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3448363-soligenix-nabs-new-patent-in-u-s-shares-up-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448358\" data-ts=\"1554379612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448358-constellation-brandsplus-4-after-strong-depletion-performance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellation Brands +4% after strong depletion performance</a></h4><ul> <li>Constellation Brands (NYSE:<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>) is <font color=\"green\">up 3.71%</font> after reporting Q4 sales ahead of expectations.</li> <li>The company says strong portfolio depletion performance was driven by the Modelo and Corona brand families. The beer business was the top U.S. share gainer during the winter holiday season driven by Modelo Especial, Corona Premier and Corona Familiar.</li> <li>Also of note, Q4 shipment volume was strong and exceeded expectations primarily due to timing. The company notes that distributor inventory levels in February are higher than planned due to muted depletion trends at the end of the quarter driven primarily by poor weather conditions for the West Coast during February. This shipment timing benefit is expected to reverse during FY20.</li> <li>Operating margin was up 250 bps to 40.5% of sales in Q4, as benefits from pricing and lower marketing spend were partially offset by higher transportation costs. Marketing costs as a percentage of sales were 6.4% vs. 8.0% a year ago.</li> <li>Looking ahead, the company sets a FY20 operating cash flow target of ~$2B and free cash flow projection of $1.1B to $1.2B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448339-constellation-brands-beats-0_12-beats-revenue\" target=\"_blank\">Constellation Brands beats by $0.12, beats on revenue</a> (April 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448358\" data-linked=\"Constellation Brands +4% after strong depletion performance\" data-tweet=\"$STZ - Constellation Brands +4% after strong depletion performance https://seekingalpha.com/news/3448358-constellation-brandsplus-4-after-strong-depletion-performance?source=tweet\" data-url=\"https://seekingalpha.com/news/3448358-constellation-brandsplus-4-after-strong-depletion-performance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}